<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Thyroidectomy</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Thyroidectomy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Thyroidectomy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tracy S Wang, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Melanie L Lyden, MD, MHPE</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Julie Ann Sosa, MD, MA, FACS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sally E Carty, MD, FACS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 11, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Over the last century, thyroid surgery has evolved from a dangerous and bloody undertaking to a safe operation with favorable outcomes but few major risks, especially when performed by experienced surgeons [<a href="#rid1">1-6</a>]. </p><p>Thyroid surgery is performed for a number of benign and malignant conditions, which are discussed in detail elsewhere (see <a class="local">'Indications'</a> below). In this topic, we discuss various surgical aspects of thyroidectomy, including preoperative evaluation and preparation, operative management, postoperative care, and complications. </p><p class="headingAnchor" id="H2"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>Thyroidectomy may be performed for a number of benign and malignant conditions, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Thyroid nodules. (See  <a class="medical medical_review" href="/z/d/html/7890.html" rel="external">"Diagnostic approach to and treatment of thyroid nodules"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperthyroidism. (See  <a class="medical medical_review" href="/z/d/html/7880.html" rel="external">"Surgical management of hyperthyroidism", section on 'Role of surgery'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obstructive or substernal goiter. (See  <a class="medical medical_review" href="/z/d/html/7820.html" rel="external">"Treatment of benign obstructive or substernal goiter", section on 'Approach to surgery'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Differentiated (papillary or follicular) thyroid cancer. (See  <a class="medical medical_review" href="/z/d/html/7821.html" rel="external">"Differentiated thyroid cancer: Surgical treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Medullary thyroid cancer. (See  <a class="medical medical_review" href="/z/d/html/2190.html" rel="external">"Medullary thyroid cancer: Surgical treatment and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anaplastic thyroid cancer. (See  <a class="medical medical_review" href="/z/d/html/2189.html" rel="external">"Anaplastic thyroid cancer", section on 'Our approach to treatment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Primary thyroid lymphoma – Primary thyroid lymphoma is treated with chemotherapy and/or radiation. The role of surgery is limited to obtaining tissue biopsy. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Metastases to the thyroid – Metastases to the thyroid gland from extrathyroidal primary cancers are rare and are most commonly from renal cell carcinoma in clinical series and the lung in autopsy series [<a href="#rid7">7-9</a>]. Local control can be achieved with thyroid surgery in patients with isolated metastasis to the thyroid.</p><p></p><p class="headingAnchor" id="H3"><span class="h1">PREOPERATIVE EVALUATION AND PREPARATION</span><span class="headingEndMark"> — </span>With few exceptions, thyroidectomy is elective surgery. Thus, any major medical issues should be addressed before proceeding to the operating room [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a> and  <a class="medical medical_review" href="/z/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk"</a>.)</p><p>All patients undergoing thyroid surgery require preoperative imaging, laboratory testing, and laryngeal examination as discussed below. Patients with hyperparathyroidism and those undergoing reoperations need additional preparation [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H279463473"><span class="h2">Thyroid imaging</span><span class="headingEndMark"> — </span>Diagnostic thyroid ultrasound is performed in all patients with a suspected thyroid nodule, nodular goiter, or thyroid abnormality detected by another imaging modality. In patients undergoing thyroid surgery for malignant conditions, ultrasound examination of the contralateral thyroid lobe as well as the lateral and central compartment cervical lymph nodes should also be performed [<a href="#rid6">6,11</a>]. (See  <a class="medical medical_review" href="/z/d/html/7859.html" rel="external">"Overview of the clinical utility of ultrasonography in thyroid disease"</a> and  <a class="medical medical_review" href="/z/d/html/7890.html" rel="external">"Diagnostic approach to and treatment of thyroid nodules", section on 'Thyroid ultrasonography'</a>.)</p><p>Additional imaging modalities, such as computed tomography (CT), positron emission tomography (PET), or magnetic resonance imaging (MRI), may be offered to patients who are suspected of harboring advanced diseases (eg, invasive primary tumor or multiple/bulky lymph node involvement) [<a href="#rid12">12</a>]. CT and MRI can detect extrathyroidal tumor extension into adjacent structures as well as substernal or retropharyngeal diseases [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/z/d/html/7821.html" rel="external">"Differentiated thyroid cancer: Surgical treatment", section on 'Importance of preoperative imaging'</a>.)</p><p class="headingAnchor" id="H3530585479"><span class="h2">Laboratory testing</span><span class="headingEndMark"> — </span>For all patients undergoing thyroid surgery, a serum thyroid-stimulating hormone (TSH) level can determine whether the patient is euthyroid, hyperthyroid, or hypothyroid. A serum calcium level can help identify patients who have concomitant parathyroid disorders [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/z/d/html/7891.html" rel="external">"Laboratory assessment of thyroid function"</a> and  <a class="medical medical_review" href="/z/d/html/2029.html" rel="external">"Primary hyperparathyroidism: Diagnosis, differential diagnosis, and evaluation"</a>.)</p><p>For patients diagnosed with medullary thyroid cancer or highly suspected to have medullary thyroid cancer based on family history, preoperative evaluation should also include measurement of serum calcitonin, carcinoembryonic antigen (CEA), genetic testing for germline <em>RET</em> mutations, and biochemical evaluation for coexisting endocrinopathies, such as hyperparathyroidism or pheochromocytoma [<a href="#rid14">14-16</a>]. Medullary thyroid cancer may be hereditary, as in multiple endocrine neoplasia type 2 (MEN2A or MEN2B) syndrome. The evaluation of patients with medullary thyroid cancer is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7848.html" rel="external">"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging", section on 'Evaluation'</a>.)</p><p>Molecular testing may be performed on the biopsy specimen. This may guide the extent of thyroidectomy. (See  <a class="medical medical_review" href="/z/d/html/116428.html" rel="external">"Evaluation and management of thyroid nodules with indeterminate cytology in adults"</a>.)</p><p class="headingAnchor" id="H569471723"><span class="h2">Laryngeal examination</span><span class="headingEndMark"> — </span>Injury or trauma to the recurrent laryngeal nerve (RLN) during thyroid surgery can result in vocal cord paralysis. Thus, occult RLN paresis and/or vocal cord paralysis diagnosed <strong>before </strong>the surgery can facilitate operative planning and patient counseling. In preoperative discussion, the surgeon should disclose to the patient the possibility, likelihood, and implications of permanent laryngeal dysfunction [<a href="#rid6">6</a>].</p><p>Preoperative assessment of the vocal cord function can be done by listening to the patient's voice, direct or indirect laryngoscopy, videostroboscopy (which provides a magnified, slow-motion view of the vocal cords), or laryngeal ultrasound [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/z/d/html/523.html" rel="external">"Inducible laryngeal obstruction (paradoxical vocal fold motion)", section on 'Laryngoscopy'</a>.)</p><p>Although some surgeons advocate routine laryngoscopy in all patients undergoing thyroidectomy because voice change was only observed in one-third of patients with a vocal cord paralysis [<a href="#rid18">18</a>], routine testing has not been shown to be either obligatory or cost effective [<a href="#rid12">12,19</a>]. Published clinical guidelines recommend performing preoperative laryngeal examination selectively in patients determined to be at high risk, including [<a href="#rid6">6,12,20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with preoperative hoarseness or voice changes</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with history of prior neck or mediastinal surgery, both thyroid and nonthyroid</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with extrathyroidal extension of tumor posteriorly</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with bulky lymphadenopathy in the central compartment or jugular chain</p><p></p><p>Additionally, invasive thyroid cancer is associated with a higher risk of occult RLN paresis/vocal cord paralysis. In one study of 365 patients, preoperative vocal cord paralysis was diagnosed by laryngoscopy in 70 percent of patients with invasive disease but only 0.3 percent of patients with noninvasive disease [<a href="#rid21">21</a>]. </p><p class="headingAnchor" id="H1675305309"><span class="h2">Preoperative management of hyperthyroidism</span><span class="headingEndMark"> — </span>According to several clinical guidelines that cover the diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis, patients undergoing surgery for hyperthyroidism should receive [<a href="#rid6">6,22</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Preoperative antithyroid medications and/or beta blockade to avoid thyroid storm.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preoperative oral Lugol's solution (potassium iodide, SSKI) to block iodine uptake and the secretion of thyroid hormone [<a href="#rid23">23</a>]. Lugol's solution may also decrease vascularity of the thyroid gland and reduce intraoperative bleeding. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preoperative vitamin D and calcium supplementation to reduce the risk of symptomatic hypocalcemia postoperatively [<a href="#rid24">24</a>]. Patients with previous gastric bypass surgery are at an increased risk for developing recalcitrant, symptomatic hypocalcemia after thyroidectomy, the management of which may be difficult [<a href="#rid25">25</a>]. </p><p></p><p>Medical optimization of patients undergoing surgery for hyperthyroidism is further discussed in another topic. (See  <a class="medical medical_review" href="/z/d/html/7880.html" rel="external">"Surgical management of hyperthyroidism", section on 'Preoperative preparation'</a>.)</p><p class="headingAnchor" id="H2829692393"><span class="h2">Reoperative thyroid surgery</span><span class="headingEndMark"> — </span>Reoperative thyroidectomy refers to thyroid surgery performed in patients who have had one or more previous thyroid surgeries or other neck operations such as cervical spine surgery via an anterior approach, parathyroidectomy, tracheostomy, or carotid endarterectomy. Reoperative thyroid surgery is technically challenging due to the presence of adhesions and scar tissues in the operative field, has different indications and strategies, and can be associated with higher rates of complications such as RLN injury and hypoparathyroidism [<a href="#rid6">6,20,26,27</a>]. </p><p>The risks and benefits should be carefully weighed before reoperative thyroid surgery, especially when options for nonoperative management exist (eg, for benign indications) [<a href="#rid20">20,26,27</a>]. Once the decision is made to operate, the surgeon must carefully review all operative and pathology reports from previous operations to determine the prior extent of disease and the visibility, location, and possible loss of parathyroid glands during the previous operations. In many cases, formal review of pathology slides from the previous surgeries may also be informative.</p><p>The timing of performing a completion thyroidectomy after a partial thyroidectomy that reveals thyroid cancer remains controversial but has not been shown to impact complication rates [<a href="#rid28">28</a>]. Many surgeons perform completion thyroidectomy either within five to seven days after the initial thyroid lobectomy before intense inflammation in the operative field has set in or delay the operation for at least six weeks to allow time for the inflammation to subside.</p><p class="headingAnchor" id="H159517350"><span class="h1">OPERATIVE MANAGEMENT</span></p><p class="headingAnchor" id="H2048798749"><span class="h2">Surgical prophylaxis</span></p><p class="headingAnchor" id="H3163883777"><span class="h3">Antibiotics</span><span class="headingEndMark"> — </span>Thyroid surgery has a very low infection rate because it is a clean procedure performed in a well-vascularized area, and thus antibiotic prophylaxis is generally not required [<a href="#rid6">6,29,30</a>]. In patients at high risk for infection, such as those with immunocompromise or poorly controlled diabetes, preoperative antibiotics such as <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">cefazolin</a> can be administered [<a href="#rid31">31,32</a>]. To be effective, preoperative prophylactic antibiotics should be administered within one hour of incision [<a href="#rid33">33-35</a>]. (See  <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">"Antimicrobial prophylaxis for prevention of surgical site infection in adults"</a>.)</p><p class="headingAnchor" id="H300049760"><span class="h3">Antiemetics</span><span class="headingEndMark"> — </span>Prophylactic antiemetics should be given because postoperative nausea and vomiting occur frequently after thyroidectomy. In one trial, a single 8 mg dose of <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">dexamethasone</a> given preoperatively significantly decreased postoperative nausea and vomiting in patients undergoing thyroidectomy [<a href="#rid36">36</a>]. The prevention and treatment of postoperative nausea and vomiting are reviewed in another topic. (See  <a class="medical medical_review" href="/z/d/html/14946.html" rel="external">"Overview of post-anesthetic care for adult patients", section on 'Postoperative nausea and vomiting'</a> and  <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">"Postoperative nausea and vomiting"</a>.) </p><p class="headingAnchor" id="H1296568124"><span class="h3">Venous thromboembolism prophylaxis</span><span class="headingEndMark"> — </span>For patients undergoing thyroid surgery under general anesthesia, mechanical methods of thromboprophylaxis, such as sequential compression devices, should be employed. After surgery, patients are encouraged to get out of bed and ambulate as early as possible; most patients are able to do so in the evening after their surgery. (See  <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">"Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"</a>.) </p><p class="headingAnchor" id="H7"><span class="h2">Anesthesia</span><span class="headingEndMark"> — </span>Thyroid surgery can be performed under general or local/regional anesthesia. While the vast majority of thyroidectomies are performed under general endotracheal anesthesia, local or regional anesthesia can be used selectively provided that the anatomy and pathology are favorable, the patient is able to communicate with the operating room staff and does not mind being conscious, and clinician expertise in performing a cervical plexus block is available  (<a class="graphic graphic_figure graphicRef82712" href="/z/d/graphic/82712.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/z/d/html/91383.html" rel="external">"Anesthesia for patients with thyroid disease and for patients who undergo thyroid or parathyroid surgery", section on 'Choice of anesthetic technique'</a>.) </p><p class="headingAnchor" id="H11"><span class="h2">Patient position and skin preparation</span><span class="headingEndMark"> — </span>The patient is placed on the operating table in a supine, semi-Fowler, or "beach-chair" position, typically with the neck in extension. A roll can be placed transversely under the scapulae to facilitate exposure of the anterior neck, and care should be taken to avoid neck hyperextension  (<a class="graphic graphic_figure graphicRef67508" href="/z/d/graphic/67508.html" rel="external">figure 2</a>).</p><p>Although issues of operative access and safety also pertain, excessive neck extension during surgery can result in postoperative pain. As an example, patients reported greater postoperative pain after undergoing thyroidectomy with than without neck extension in a randomized trial [<a href="#rid37">37</a>]. Extensive hyperextension of the neck can also lead to vertigo, headache, and postoperative nausea [<a href="#rid38">38</a>]. Patients with known cervical spine disease should be assessed preoperatively by an orthopedic surgeon or neurosurgeon. </p><p>The skin of the anterior neck, from the lower lip/angle of the mandible to the anterior chest, should be prepared. If mediastinal surgery is contemplated, the entire chest should be prepared and included in the operative field. </p><p class="headingAnchor" id="H12"><span class="h2">Incision</span><span class="headingEndMark"> — </span>A Kocher (or collar) incision is made sharply on the anterior aspect of the midneck. Efforts should be made to place this incision in an existing skin crease if possible. The incision length should be based on the size of the underlying thyroid gland as well as patient body habitus [<a href="#rid39">39</a>]. A longer incision may be needed if the patient is obese, the gland is large, or the neck is foreshortened, as with kyphoscoliosis  (<a class="graphic graphic_figure graphicRef111541" href="/z/d/graphic/111541.html" rel="external">figure 3</a>).</p><p class="headingAnchor" id="H13"><span class="h2">Exposure</span><span class="headingEndMark"> — </span>After the incision, dissection is carried down to the platysma muscle. A layer that is only a few millimeters thick, the platysma muscle is divided along the course of the incision with cautery. Subplatysmal flaps are then elevated to above the level of the thyroid cartilage superiorly, over the sternocleidomastoid muscles laterally, and the level of the sternal notch inferiorly  (<a class="graphic graphic_figure graphicRef111543" href="/z/d/graphic/111543.html" rel="external">figure 4</a>).</p><p>The raphe between the strap muscles is opened in the midline avascular plane. Any enlarged lymph nodes in the midline prelaryngeal area (Delphian nodes) should be excised because they can portend locally metastatic disease. The strap muscles, which include the sternothyroid and sternohyoid muscles, are routinely preserved. However, if the thyroid tumor is adherent to or frankly invades the strap muscles, any involved portion of the muscles should be resected en bloc with the tumor to maintain a negative margin. </p><p class="headingAnchor" id="H14"><span class="h2">Dissection of the thyroid gland</span></p><p class="bulletIndent1"><span class="glyph">●</span>Starting with the isthmus, one lobe of the thyroid gland is dissected from medial to lateral across the anterior capsule. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When the lateral border of that lobe is reached, the middle thyroid vein should be identified and divided. The thyroid lobe is then rolled lateral to medial to display its posterior capsule and the tracheoesophageal groove, taking care not to enter the thyroid capsule  (<a class="graphic graphic_figure graphicRef82298" href="/z/d/graphic/82298.html" rel="external">figure 5</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The superior pole vessels are dissected out and ligated as close as possible to the thyroid capsule  (<a class="graphic graphic_figure graphicRef81126" href="/z/d/graphic/81126.html" rel="external">figure 6</a>). All thyroid tissues from the superior pole area are then removed. The external branch of the superior laryngeal nerve crosses the vessels close to the superior pole of the thyroid. Retraction of the superior pole in a lateral and inferior direction during dissection can facilitate visualization of the nerve. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dissection then continues down along the lateral aspect of the thyroid lobe. Mobilization of the superior pole may aid in the identification of the recurrent laryngeal nerve (RLN). The RLN should be visually identified in the tracheoesophageal groove and protected through its course. Placement of an oral or nasogastric tube, an esophageal stethoscope, or a temperature probe facilitates identification of the tracheoesophageal groove and the RLN. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The inferior vascular pedicle, along with any other blood vessels going to and from the thyroid in its vicinity, should be ligated, which allows the thyroid lobe to be rolled up and onto the anterior surface of the trachea  (<a class="graphic graphic_figure graphicRef50925" href="/z/d/graphic/50925.html" rel="external">figure 7</a>). A trial of 319 patients undergoing total thyroidectomy reported that dissection along the thyroid capsule with branch ligation of the inferior thyroid arteries resulted in a lower rate of transient hypocalcemia compared with truncal ligation of the inferior thyroid arteries (3.1 versus 22.9 percent) [<a href="#rid40">40</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The ligament of Berry should be divided as close to the trachea as possible near the insertion of the RLN or its branches into the cricopharyngeus muscle  (<a class="graphic graphic_figure graphicRef55871" href="/z/d/graphic/55871.html" rel="external">figure 8</a>). Great care has to be taken with this step because the ligament of Berry is the most common site of injury for the RLN  (<a class="graphic graphic_figure graphicRef74541" href="/z/d/graphic/74541.html" rel="external">figure 9</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The isthmus should then be separated from the anterior aspect of the trachea, and the pyramidal lobe followed as cephalad as possible and resected en bloc with the thyroid  (<a class="graphic graphic_figure graphicRef55774" href="/z/d/graphic/55774.html" rel="external">figure 10</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For a thyroid lobectomy and isthmusectomy, the dissection is then complete. A heavy clamp (eg, Kelly clamp) can be applied across the junction of the isthmus and the contralateral thyroid lobe, the thyroid sharply divided, and the stump oversewn with a hemostatic absorbable suture  (<a class="graphic graphic_figure graphicRef67518" href="/z/d/graphic/67518.html" rel="external">figure 11</a>). Alternatively, a harmonic scalpel can be employed to divide the isthmus. The specimen is then oriented and labeled for pathology. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For a total thyroidectomy, dissection continues onto the contralateral lobe using gentle traction of the mobilized isthmus to help expose that lobe. If any type of central neck dissection or cervical thymectomy is to be performed, it can be done en bloc with the thyroidectomy specimen or separately after the thyroid lobe or gland has been removed.</p><p></p><p class="headingAnchor" id="H3743729998"><span class="h2">Closure</span><span class="headingEndMark"> — </span>Prior to closure, the surgical field is evaluated for hemostasis. The strap muscles are then reapproximated with absorbable interrupted sutures at the midline  (<a class="graphic graphic_figure graphicRef110158" href="/z/d/graphic/110158.html" rel="external">figure 12</a>). The platysma muscle is closed, followed by skin closure with sutures or skin glue.</p><p class="headingAnchor" id="H462699689"><span class="h2">Extent of resection</span><span class="headingEndMark"> — </span>The extent of initial thyroidectomy for certain thyroid diseases remains controversial. We suggest the following approaches, which are consistent with published clinical guidelines [<a href="#rid12">12</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Total thyroidectomy is the procedure of choice for patients with Graves' disease, medullary thyroid cancer, and for those with a high-risk differentiated thyroid cancer. High-risk differentiated thyroid cancer is defined by tumor ≥4 cm or with gross extrathyroidal extension, clinically apparent metastatic lymph nodes or distant metastases, or thyroid cancer in a patient with prior radiation to the head and neck or family history of differentiated thyroid cancer in a first-degree relative [<a href="#rid41">41-43</a>]. (See  <a class="medical medical_review" href="/z/d/html/7838.html" rel="external">"Differentiated thyroid cancer: Overview of management"</a> and  <a class="medical medical_review" href="/z/d/html/2190.html" rel="external">"Medullary thyroid cancer: Surgical treatment and prognosis"</a> and  <a class="medical medical_review" href="/z/d/html/7880.html" rel="external">"Surgical management of hyperthyroidism"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Either a total thyroidectomy or a thyroid lobectomy may be performed in patients with a low-risk differentiated thyroid cancer, including those with a differentiated thyroid cancer between 1 and 4 cm without gross evidence of extrathyroidal extension or clinical evidence of central or lateral compartment lymph node metastases [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/7821.html" rel="external">"Differentiated thyroid cancer: Surgical treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Unifocal differentiated thyroid cancers that are &lt;1 cm (papillary thyroid microcarcinoma) may undergo active surveillance or thyroid lobectomy. Ideal patients for active surveillance include those with solitary tumors ≤1 cm with well-defined margins and no evidence of lymph node metastases, who are older than 60 years, who understand that surgery may be recommended in the future, and who are being managed by an experienced team [<a href="#rid44">44,45</a>]. When surgery is planned, thyroid lobectomy is appropriate for most patients; in patients with a familial thyroid cancer and/or a history of radiation to the face, neck, or chest, total thyroidectomy should be performed. (See  <a class="medical medical_review" href="/z/d/html/7821.html" rel="external">"Differentiated thyroid cancer: Surgical treatment"</a> and  <a class="medical medical_review" href="/z/d/html/7890.html" rel="external">"Diagnostic approach to and treatment of thyroid nodules", section on 'Malignant (Bethesda VI)'</a>.) </p><p></p><p>In operative management, the minimum acceptable extent of thyroidectomy for unilateral diseases is a complete ipsilateral lobectomy. Incomplete thyroid resections, such as thyroid "nodulectomy" or partial lobectomy, are no longer performed, because they predispose patients to disease recurrence, scar tissue, and the need for reoperations. </p><p>Graves' disease or multinodular nontoxic goiter can best be treated with total thyroidectomy. Less extensive techniques, such as unilateral lobectomy and isthmusectomy (Dunhill operation) or bilateral subtotal thyroidectomy, are not recommended, because they either carry a greater risk of disease recurrence [<a href="#rid41">41-43</a>] or a greater risk of complications (eg, RLN injury or hypoparathyroidism) if a reoperation is required [<a href="#rid20">20,26,27</a>]. (See  <a class="medical medical_review" href="/z/d/html/7880.html" rel="external">"Surgical management of hyperthyroidism", section on 'Extent of resection'</a>.)</p><p class="headingAnchor" id="H724879534"><span class="h2">Lymphadenectomy</span><span class="headingEndMark"> — </span>The extent of lymphadenectomy required at the time of thyroid surgery is based on the type of thyroid malignancy and its risk of lymph node metastasis [<a href="#rid11">11,12</a>]. (See  <a class="medical medical_review" href="/z/d/html/15033.html" rel="external">"Neck dissection for differentiated thyroid cancer"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>All patients with a medullary, papillary, or follicular thyroid cancer and clinical or radiological evidence of lymphadenopathy should undergo a <strong>therapeutic</strong> lymphadenectomy of the appropriate compartment(s) at the time of their initial thyroid surgery  (<a class="graphic graphic_figure graphicRef67441" href="/z/d/graphic/67441.html" rel="external">figure 13</a> and <a class="graphic graphic_figure graphicRef54099" href="/z/d/graphic/54099.html" rel="external">figure 14</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prophylactic</strong> lymphadenectomy should be performed only in the following situations:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with medullary thyroid cancer, the central compartment (level VI) nodes should be removed prophylactically. (See  <a class="medical medical_review" href="/z/d/html/2190.html" rel="external">"Medullary thyroid cancer: Surgical treatment and prognosis", section on 'Surgical approach'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with papillary thyroid cancer, a prophylactic central neck lymphadenectomy can be performed in patients with large (≥4 cm) tumors or extrathyroidal extension. Thyroidectomy can be performed without central lymphadenectomy in patients who have small (&lt;4 cm) tumors without extrathyroidal extension or lymph node involvement. This approach resulted in a local recurrence rate of only 5 percent [<a href="#rid46">46</a>]. A 2022 systematic review and meta-analysis of five randomized trials of clinically node-negative papillary thyroid cancer found no difference in the rates of locoregional recurrence, hypoparathyroidism, recurrent laryngeal nerve injury, and bleeding between total thyroidectomy alone and total thyroidectomy plus prophylactic central neck dissection [<a href="#rid47">47</a>]. (See  <a class="medical medical_review" href="/z/d/html/7821.html" rel="external">"Differentiated thyroid cancer: Surgical treatment", section on 'Approach to lymph node dissection'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Since follicular thyroid cancer spreads hematogenously, and oncocytic (formerly known as Hürthle cell) thyroid cancer rarely spreads lymphatically, there is little role for prophylactic cervical lymphadenectomy in either patient population. (See  <a class="medical medical_review" href="/z/d/html/7821.html" rel="external">"Differentiated thyroid cancer: Surgical treatment", section on 'Approach to lymph node dissection'</a>.)</p><p></p><p class="headingAnchor" id="H2147929003"><span class="h2">Parathyroid glands</span><span class="headingEndMark"> — </span>Most patients have four parathyroid glands in close association with the thyroid gland. Identification and preservation of the parathyroid glands is essential during thyroidectomy. </p><p class="headingAnchor" id="H15"><span class="h3">Parathyroid preservation</span><span class="headingEndMark"> — </span>Knowledge of the surgical anatomy is important for the identification of parathyroid glands during thyroid dissection. The superior parathyroid glands are located posterior to the RLN; the inferior parathyroid glands are located anterior to the RLN  (<a class="graphic graphic_figure graphicRef56752" href="/z/d/graphic/56752.html" rel="external">figure 15</a>). (See  <a class="medical medical_review" href="/z/d/html/2156.html" rel="external">"Surgical anatomy of the parathyroid glands"</a>.)</p><p>To avoid injuring the parathyroid glands, the thyroid dissection should be carried out as close to the capsule as possible while ensuring extirpation of all visible thyroid tissues. Once identified, parathyroid glands should be preserved in situ on their native vascular pedicles. The inferior thyroid artery supplies 80 percent of the parathyroid glands. Thus, the inferior thyroid artery must be ligated close to the thyroid capsule to avoid encroaching upon the branches supplying the parathyroid glands, which take off more laterally  (<a class="graphic graphic_figure graphicRef56752" href="/z/d/graphic/56752.html" rel="external">figure 15</a>). </p><p>Parathyroid glands should not be removed during thyroid surgery unless they are grossly invaded by a thyroid malignancy or become severely ischemic during dissection. In the latter case, the parathyroid gland can be autotransplanted into a well-vascularized muscle such as the strap or sternocleidomastoid muscles [<a href="#rid48">48</a>]. (See <a class="local">'Parathyroid autotransplantation'</a> below.)</p><p>Newer technology such as <a class="drug drug_general" data-topicid="8982" href="/z/d/drug information/8982.html" rel="external">indocyanine green</a> fluorescence or near-infrared autofluorescence can be used to identify parathyroid glands and assess parathyroid viability to guide autotransplantation. Advances in the field of near-infrared autofluorescence technology for the identification and localization of parathyroid glands led to US Food and Drug Administration approval of two near-infrared fluorescence detection devices. While additional validation studies are required, better identification and localization of parathyroid glands may lead to a decrease in postoperative hypoparathyroidism [<a href="#rid49">49-51</a>]. (See <a class="local">'Hypocalcemia/hypoparathyroidism'</a> below.) </p><p class="headingAnchor" id="H3298322672"><span class="h3">Parathyroid enlargement</span><span class="headingEndMark"> — </span>One or more enlarged parathyroid glands can be incidentally found during thyroid surgery in normocalcemic patients. Management depends upon the number of glands that are enlarged:</p><p class="bulletIndent1"><span class="glyph">●</span>Resection of a single incidentally encountered enlarged parathyroid gland is usually appropriate [<a href="#rid52">52</a>]. An intraoperative parathyroid hormone (PTH) level should be obtained, if possible, to document occult hyperparathyroidism before the enlarged gland is resected. If an abnormal gland is resected, a postoperative calcium and/or PTH level should also be obtained to document adequate resection of presumed parathyroid disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If all four parathyroid glands appear enlarged and the patient is known to be normocalcemic and have normal renal function, vitamin D deficiency should be suspected. Resection of the glands is <strong>not</strong> recommended.</p><p></p><p class="headingAnchor" id="H16"><span class="h3">Parathyroid autotransplantation</span><span class="headingEndMark"> — </span>A normal-sized parathyroid gland of uncertain viability or an intracapsular/intrathyroidal gland that cannot be sustained by its native vascular pedicle should be autotransplanted into the ipsilateral strap or sternocleidomastoid muscle. In healthy muscle, parathyroid cells can stimulate neovascularization by releasing vascular endothelial growth factor [<a href="#rid53">53</a>]. The technique of parathyroid autotransplantation is described in detail in another topic. (See  <a class="medical medical_review" href="/z/d/html/15041.html" rel="external">"Parathyroidectomy in end-stage kidney disease", section on 'Creating an autograft'</a>.)</p><p>Autotransplantation should not be performed if a parathyroid gland has obvious tumor involvement. Before transplantation, frozen section of a small portion of the gland may be performed to ensure that the tissue is indeed of parathyroid origin, rather than of a metastatic lymph node or a portion of the thyroid gland. Fine-needle aspiration followed by rapid intraoperative PTH measurement of the aspirate is another way to confirm parathyroid tissue. (See <a class="local">'Intraoperative frozen section analysis'</a> below and  <a class="medical medical_review" href="/z/d/html/15031.html" rel="external">"Intraoperative parathyroid hormone assays", section on 'Identifying parathyroid tissue'</a>.)</p><p class="headingAnchor" id="H3588087403"><span class="h2">Optional techniques and equipment</span><span class="headingEndMark"> — </span>Intraoperative nerve monitoring and intraoperative frozen section analysis are two optional techniques that can be used to augment thyroid surgery. Drains and vessel sealing devices are optional equipment that can be used to facilitate thyroid surgery.</p><p class="headingAnchor" id="H20"><span class="h3">Intraoperative nerve monitoring</span><span class="headingEndMark"> — </span>Intraoperative nerve monitoring (IONM) has been advocated with the goal of reducing the rate of RLN injury. Although its routine use remains controversial [<a href="#rid6">6</a>], it could potentially assist in the identification, dissection, and prediction of postoperative function of the RLN [<a href="#rid54">54</a>]. </p><p class="headingAnchor" id="H3280272479"><span class="h4">Techniques of nerve monitoring</span><span class="headingEndMark"> — </span>The two main components of IONM are nerve stimulation and assessment of vocal fold response to nerve stimulation.</p><p class="headingAnchor" id="H4091711075"><span class="h5">Nerve stimulation</span><span class="headingEndMark"> — </span>The RLN can be stimulated with a low-voltage electric current delivered by a handheld probe (intermittent stimulation) or an electrode attached to the ipsilateral vagus nerve (intermittent or continuous stimulation).</p><p>Continuous stimulation could alert the surgeon to an impending nerve injury earlier than intermittent stimulation. However, continuous IONM has the disadvantages of potentially causing vagal neurapraxia (if the electrode dislodges) or hemodynamic instability (eg, cardiac arrest) secondary to increased parasympathetic (vagal) tone [<a href="#rid55">55</a>]. It also requires dissection of structures (eg, vagus nerve) outside of the typical operative field, although a transcutaneous method of vagal stimulation for IONM during endocrine surgery has been reported [<a href="#rid56">56</a>]. </p><p class="headingAnchor" id="H1170598684"><span class="h5">Vocal fold response</span><span class="headingEndMark"> — </span>The vocal fold response to nerve stimulation is most commonly measured by a laryngeal surface electrode system built into or attached to the endotracheal tube [<a href="#rid57">57-59</a>], which is positioned at a level that enables the vocal cords to come into contact with the electrodes [<a href="#rid60">60</a>]. </p><p>During surgery, the vocal fold response to nerve stimulation is displayed on a nerve monitor as auditory or visual electromyographic (EMG) signals. Changes in the pattern of EMG signals, which can occur with retraction of the gland, dissection of surrounding tissues, or dissection of the RLN itself, can alert the surgeon to possible nerve irritation [<a href="#rid57">57,58</a>].</p><p>Because vocal fold response is measured by EMG activities, only short-acting muscle relaxants, such as <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a>, should be used during induction of anesthesia when IONM is employed. No paralytic agents should be used after induction to prevent interference with obtaining an EMG signal.</p><p class="headingAnchor" id="H418446469"><span class="h4">Efficacy of nerve monitoring</span><span class="headingEndMark"> — </span>Regardless of whether IONM is used during endocrine surgery, surgeons should exercise the same vigilance with surgical techniques to avoid RLN injury. When IONM is used, it is to augment, rather than circumvent, the need for meticulous surgical techniques, including intraoperative visual identification of the RLN. </p><p>Most studies examining the utility of IONM have been observational; the few randomized trials were small and underpowered. A 2019 Cochrane systematic review and meta-analysis of five trials found no advantage or disadvantage for IONM in either permanent (relative risk 0.77, 95% CI 0.33-1.77) or transient RLN palsy (relative risk 1.25; 95% CI 0.45-3.47), when compared with visual nerve identification [<a href="#rid61">61</a>]. A 2022 meta-analysis of eight trials similarly found no improvement with IONM in either permanent (IONM 0.5 percent versus visual nerve identification 0.6 percent, p = 0.57) or transient (1.5 versus 2.1 percent, p = 0.11) RLN injury, although there was a nonstatistically significant reduction in overall RLN injury (3.2 versus 2.3 percent, p = 0.069) [<a href="#rid62">62</a>]. </p><p>Existing data do not support that the routine use of IONM reduces the incidence of RLN injury [<a href="#rid59">59,60,63-68</a>]. IONM, however, may be beneficial in procedures that are either high risk or performed by low-volume surgeons [<a href="#rid59">59,69-71</a>]. High-risk procedures in this context typically include reoperations and those performed for thyroid cancers or goiters (retrosternal or toxic). </p><p>During planned total thyroidectomy, after completion of the initial lobectomy if IONM results suggest loss of function, the surgeon may consider stopping the operation for possible completion at a later date [<a href="#rid6">6</a>]. </p><p class="headingAnchor" id="H3494895739"><span class="h3">Intraoperative frozen section analysis</span><span class="headingEndMark"> — </span>In contemporary practice, frozen section analysis is no longer widely used and is only reserved for a few situations in which it could have an impact on surgical decision making [<a href="#rid72">72</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>To diagnose thyroid malignancies intraoperatively when the preoperative cytology was atypical or suspicious, thus potentially informing the need for a completion thyroidectomy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>To diagnose lymph node metastasis, which may help guide the decision to perform a therapeutic central compartment neck dissection. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>To confirm parathyroid tissue [<a href="#rid73">73</a>].</p><p></p><p class="headingAnchor" id="H21"><span class="h3">Drains</span><span class="headingEndMark"> — </span>Routine drain placement after thyroid surgery is not necessary [<a href="#rid74">74,75</a>]. A meta-analysis of 11 randomized trials found no significant difference in the incidences of hematoma or seroma formation between routine drainage and no drainage [<a href="#rid75">75</a>].</p><p>However, if the thyroid is very large, the dissection is extensive, or the thyroid bed is persistently oozing, a closed suction drain can be placed to prevent fluid collection [<a href="#rid75">75</a>]. The drain can be removed safely without concern for fluid reaccumulation when the output is serous and decreasing in volume.</p><p class="headingAnchor" id="H22"><span class="h3">Vessel sealing devices</span><span class="headingEndMark"> — </span>Various vessel sealing systems, such as the harmonic scalpel and LigaSure, have been employed successfully in thyroid surgery [<a href="#rid76">76</a>]. The decision to use a vessel sealing device and the choice of the device are based on surgeon and hospital preference [<a href="#rid77">77</a>]. However, just like monopolar electrocautery, vessel sealing devices should not be used within 3 to 5 mm of the RLN to avoid injury. </p><p>In a propensity score matched study of over 6500 procedures, the use of a vessel sealing device was associated with a decreased rate of neck hematoma (odds ratio 2.33, 95% CI 1.55-3.49) but no increase in the rate of RLN injuries compared with conventional hemostasis [<a href="#rid78">78</a>].</p><p class="headingAnchor" id="H3911869564"><span class="h2">Minimally invasive thyroid surgery</span><span class="headingEndMark"> — </span>In general, remote-access thyroidectomy procedures are controversial and should only be performed in carefully selected patients and by surgeons experienced in the approach [<a href="#rid6">6</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Endoscopic thyroidectomy – Endoscopic or endoscopic-assisted thyroidectomy is also termed minimally invasive video-assisted thyroidectomy (MIVAT). One approach of MIVAT employs small conventional retractors and 2 mm dissecting instruments placed through a small incision in the central neck 2 cm above the sternal notch [<a href="#rid79">79,80</a>]. Hemostasis is achieved by using a harmonic scalpel [<a href="#rid79">79</a>]. Matched comparisons between endoscopic-assisted and conventional thyroidectomy in patients with low- to intermediate-risk papillary thyroid carcinoma showed comparable surgical and oncologic outcomes [<a href="#rid80">80,81</a>]. The main advantage of MIVAT over conventional thyroidectomy is that of a smaller incision. MIVAT has also been performed via transaxillary, retroauricular, and even transoral (experimental) approaches. These alternative approaches do not require a cervical incision [<a href="#rid82">82</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Robotic surgery – Minimally invasive thyroid surgery can be performed with or without robotic assistance. The robotic technology allows for improved maneuverability of the endoscopic instruments and better ergonomics for the surgeon. However, robotic surgery is associated with a steep learning curve, a significantly longer operating room time, and a higher cost compared with conventional thyroidectomy or minimally invasive thyroid surgery performed without robotic assistance. </p><p></p><p class="bulletIndent1">Robotic-assisted minimally invasive thyroid surgery is investigational and can be performed via transoral or transaxillary routes in a select subset of patients [<a href="#rid83">83</a>]. In a meta-analysis, robotic thyroidectomy was as safe as open thyroidectomy and was associated with less blood loss, a lower level of swallowing impairment, and better cosmetic satisfaction [<a href="#rid84">84</a>]. The oncologic outcomes for those who have thyroid cancer, however, remain to be determined. In addition, use of the robotic platform for thyroidectomy remains an off-label use of the device.</p><p></p><p class="headingAnchor" id="H23"><span class="h1">POSTOPERATIVE CARE</span></p><p class="headingAnchor" id="H854160714"><span class="h2">Inpatient versus outpatient surgery</span><span class="headingEndMark"> — </span>After thyroid surgery, patients may be admitted for overnight observation to manage pain, nausea, or hypocalcemia and to monitor for hematoma formation. Select patients can undergo outpatient thyroid surgery if it is performed by experienced surgeons [<a href="#rid85">85</a>]. In a series of 1168 thyroidectomies, nearly 20 percent were performed as outpatient procedures, mostly by high-volume surgeons at high-volume centers [<a href="#rid86">86</a>]. In that series, the readmission rate after outpatient surgery was comparable to that of inpatient surgery (1.4 versus 2.4 percent).</p><p class="headingAnchor" id="H455137321"><span class="h2">Pain control</span><span class="headingEndMark"> — </span>After thyroidectomy, pain is generally reported as minimal in patients who receive preoperative education about the issue. Counseling together with nonopioid (nonsteroidal) and nonpharmacologic therapies should be the first-line management strategy, and if opioids are provided, the lowest effective dose of immediate-release opioids (&lt;10 oral <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> equivalents) should be prescribed [<a href="#rid6">6</a>]. In a trial of 95 patients undergoing thyroid surgery, those treated with nonopioid analgesia (<a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> and <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a>) had similar pain scores to those treated with opioids up to the first postoperative visit [<a href="#rid87">87</a>]. In another study, over half of the patients did not take opioid medications after cervical endocrine surgery, even though most were prescribed them [<a href="#rid88">88</a>].</p><p class="headingAnchor" id="H24"><span class="h2">Thyroid hormone supplementation</span><span class="headingEndMark"> — </span>The requirement for thyroid hormone supplementation after thyroid surgery depends upon the patient's diagnosis (benign versus malignant disease) and the extent of their resection (total thyroidectomy versus thyroid lobectomy).</p><p class="headingAnchor" id="H1498994539"><span class="h3">Benign disease except hyperthyroidism</span><span class="headingEndMark"> — </span>Patients who undergo total thyroidectomy for benign disease are typically started on a daily dose of <a class="drug drug_general" data-topicid="9557" href="/z/d/drug information/9557.html" rel="external">levothyroxine</a> at approximately 1.6 mcg/kg body weight after surgery. Patients over 65 years should be started at a lower dose; men may require higher doses than women. Approximately six weeks after starting levothyroxine, serum thyroid-stimulating hormone (TSH) should be measured and levothyroxine dose adjusted to keep TSH in the normal range. After that, annual TSH measurements are sufficient for patients who are clinically doing well. Those who display symptoms of either hypo- or hyperthyroidism require further evaluation and adjustment of their medications. </p><p>Patients who undergo thyroid lobectomy for benign disease are not routinely started on <a class="drug drug_general" data-topicid="9557" href="/z/d/drug information/9557.html" rel="external">levothyroxine</a> after surgery, but approximately one-third of them may require levothyroxine supplementation to maintain a normal TSH level. The possibility of permanent hypothyroidism should be discussed with patients prior to any thyroid surgery, including thyroid lobectomy [<a href="#rid89">89</a>]. A TSH level should be obtained approximately six weeks after surgery to determine the need for thyroid hormone replacement. (See  <a class="medical medical_review" href="/z/d/html/7855.html" rel="external">"Treatment of primary hypothyroidism in adults"</a>.)</p><p class="headingAnchor" id="H1333955388"><span class="h3">Hyperthyroidism</span><span class="headingEndMark"> — </span>Patients who undergo thyroidectomy for hyperthyroidism require special attention perioperatively. The postoperative management of these patients is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7880.html" rel="external">"Surgical management of hyperthyroidism", section on 'Postoperative management'</a>.)</p><p class="headingAnchor" id="H2788896"><span class="h3">Malignant disease</span><span class="headingEndMark"> — </span>The requirement for thyroid hormone replacement in patients who undergo total thyroidectomy for malignant disease depends on the stage of their disease, the aggressiveness of the cancer, and the need for radioiodine ablation (RAI) postoperatively. (See  <a class="medical medical_review" href="/z/d/html/7821.html" rel="external">"Differentiated thyroid cancer: Surgical treatment", section on 'Postoperative thyroid hormone therapy'</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are scheduled to receive RAI within two to three weeks of surgery may be discharged home without any thyroid hormone replacement. Thyroid hormone withdrawal raises the TSH level, which stimulates radioiodine uptake and improves the efficacy of RAI. Alternatively, patients may be started on <a class="drug drug_general" data-topicid="9557" href="/z/d/drug information/9557.html" rel="external">levothyroxine</a> in anticipation of use of recombinant human thyrotropin (rhTSH) prior to RAI. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are not scheduled to receive RAI within two or three weeks of surgery may be discharged on <a class="drug drug_general" data-topicid="9563" href="/z/d/drug information/9563.html" rel="external">liothyronine</a> (T3). Liothyronine is a short-acting thyroid hormone, the level of which can be manipulated to optimize the energy level of the patient. Based on the patient's weight and age, the starting dose of liothyronine is typically 10 to 25 mcg twice a day. Symptoms of dizziness, palpitation, or insomnia may require immediate lowering of the liothyronine dose. Liothyronine is discontinued one to two weeks prior to RAI treatment to induce thyroid hormone withdrawal. (See  <a class="medical medical_review" href="/z/d/html/7818.html" rel="external">"Differentiated thyroid cancer: Radioiodine treatment", section on 'Patient preparation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another option for patients who have a low-risk differentiated thyroid cancer is to be started on <a class="drug drug_general" data-topicid="9557" href="/z/d/drug information/9557.html" rel="external">levothyroxine</a> immediately after surgery, followed by recombinant human thyrotropin (rhTSH) just prior to RAI to activate TSH receptors [<a href="#rid90">90</a>]. (See  <a class="medical medical_review" href="/z/d/html/7818.html" rel="external">"Differentiated thyroid cancer: Radioiodine treatment", section on 'Recombinant human TSH'</a>.)</p><p></p><p>After RAI, patients should be maintained on <a class="drug drug_general" data-topicid="9557" href="/z/d/drug information/9557.html" rel="external">levothyroxine</a> at a daily dose of approximately 1.6 mcg/kg body weight. The actual target of TSH suppression will depend on the patient's age as well as the stage and aggressiveness of the cancer [<a href="#rid91">91</a>]. (See  <a class="medical medical_review" href="/z/d/html/7838.html" rel="external">"Differentiated thyroid cancer: Overview of management", section on 'Thyroid hormone suppression'</a>.)</p><p class="headingAnchor" id="H25"><span class="h2">Calcium supplementation</span><span class="headingEndMark"> — </span>Calcium supplementation after thyroid surgery is typically given orally as <a class="drug drug_general" data-topicid="9185" href="/z/d/drug information/9185.html" rel="external">calcium carbonate</a>, 1250 to 2500 mg daily total, divided in two to four doses, with the starting dose adjusted and eventually tapered off based on symptoms and/or calcium levels. Patients who take a proton pump inhibitor or have had gastric bypass surgery should take <a class="drug drug_general" data-topicid="8829" href="/z/d/drug information/8829.html" rel="external">calcium citrate</a> instead due to their lack of gastric acid, which is required for optimal absorption of calcium carbonate. </p><p>Intravenous calcium is occasionally required in patients with persistently low calcium levels and symptoms despite oral supplementation. In such patients, peripheral intravenous (IV) infusion sites should be carefully monitored because infiltration of a solution containing calcium can result in soft tissue loss. Patients can be discharged on oral calcium supplementation when their hypocalcemic symptoms resolve and their serum calcium levels stabilize at ≥7.8 mg/dL. (See  <a class="medical medical_review" href="/z/d/html/826.html" rel="external">"Treatment of hypocalcemia"</a>.)</p><p>Persistent hypocalcemia should also prompt measurement of serum magnesium with repletion if necessary. In a large database study, magnesium disorders were associated with the greatest odds of short- and long-term postoperative hypocalcemia [<a href="#rid92">92</a>].</p><p>In addition to calcium, patients with very low or undetectable parathyroid hormone (PTH) levels may need 1,25-dihydroxyvitamin D (<a class="drug drug_general" data-topicid="9183" href="/z/d/drug information/9183.html" rel="external">calcitriol</a>) to adequately absorb calcium. In such patients, calcitriol can be started prior to thyroid surgery and gradually tapered postoperatively according to the PTH and/or calcium levels [<a href="#rid93">93</a>]. Patients should continue to be monitored for both hypocalcemia (as calcitriol can take 24 to 48 hours to achieve maximal effect) and potential resultant hypercalcemia. If discharged on calcitriol, repeat laboratory tests within three to five days of discharge should be obtained. (See  <a class="medical medical_review" href="/z/d/html/826.html" rel="external">"Treatment of hypocalcemia"</a>.)</p><p>While all symptomatic hypocalcemia patients require treatment with intravenous or oral calcium, asymptomatic patients may or may not receive calcium supplementation at the surgeon's discretion:</p><p class="bulletIndent1"><span class="glyph">●</span>Some surgeons only prescribe calcium supplementation to patients with low postoperative serum calcium levels and/or low PTH [<a href="#rid94">94-97</a>]. (See  <a class="medical medical_review" href="/z/d/html/833.html" rel="external">"Clinical manifestations of hypocalcemia"</a> and  <a class="medical medical_review" href="/z/d/html/837.html" rel="external">"Diagnostic approach to hypocalcemia"</a> and  <a class="medical medical_review" href="/z/d/html/837.html" rel="external">"Diagnostic approach to hypocalcemia", section on 'Serum PTH concentrations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a study of 120 patients who underwent total or near-total thyroidectomy, low total (&lt;7.2 mg/dL) or ionized (&lt;1.0 mmol/L) serum calcium level at 16 hours postoperatively identified 94.5 percent of patients who needed calcium supplementation [<a href="#rid95">95</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a prospective study of 143 patients undergoing total thyroidectomy, the 112 patients who had a PTH level ≥10 pg/mL on the first postoperative day were discharged without calcium supplementation; only 10 percent developed hypocalcemic symptoms [<a href="#rid94">94</a>]. By contrast, almost one-half of the other 31 patients who had postoperative day 1 PTH level &lt;10 pg/mL developed hypocalcemia despite some receiving calcium supplementation. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In another prospective observational study of 123 patients undergoing total or completion thyroidectomy, an 80 percent decrease in intact PTH (iPTH) level postoperatively compared with preoperatively was 100 percent sensitive in predicting clinical hypocalcemia, whereas a postoperative iPTH level of &lt;3 pg/mL was 100 percent specific. Thus, patients with a &lt;80 percent decrease in iPTH, those with an iPTH decrease of ≥80 percent but a postoperative iPTH ≥3 pg/mL, and those with a postoperative iPTH level of &lt;3 pg/mL are at very low, intermediate, and very high risk of developing hypocalcemia, respectively [<a href="#rid98">98</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>However, a 2018 systematic review found that the existing literature regarding the use of PTH levels to predict post-thyroidectomy hypocalcemia is extremely heterogeneous. With a false negative rate as high as 54 percent, and a false positive rate as high as 70 percent, a single PTH threshold may not be a reliable measure of hypocalcemia [<a href="#rid99">99</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other surgeons prescribe calcium supplementation routinely to all patients after thyroidectomy to prevent symptoms of hypocalcemia [<a href="#rid100">100</a>]. In a small randomized trial of 79 patients undergoing total thyroidectomy, routine administration of oral calcium and vitamin D reduced both the incidence and severity of hypocalcemia symptoms [<a href="#rid93">93</a>]. In a meta-analysis of 15 studies, routine supplementation with calcium and <a class="drug drug_general" data-topicid="10117" href="/z/d/drug information/10117.html" rel="external">vitamin D3</a> after thyroidectomy was associated with a lower risk of symptomatic hypocalcemia (risk difference -0.25, 95% CI -0.32 to -0.18) and biochemical hypocalcemia (risk difference -0.24, 95% CI -0.31 to -0.17) compared with treatment based on measured calcium levels [<a href="#rid101">101</a>]. </p><p></p><p class="headingAnchor" id="H26"><span class="h2">Follow-up</span><span class="headingEndMark"> — </span>A follow-up visit should be scheduled in one to two weeks after surgery to:</p><p class="bulletIndent1"><span class="glyph">●</span>Evaluate and manage incisional healing.</p><p class="bulletIndent1"><span class="glyph">●</span>Evaluate the patient for any unusual voice changes, subtle hypocalcemic symptoms, and overall recovery. </p><p class="bulletIndent1"><span class="glyph">●</span>Adjust doses of medications, including those of thyroid hormone replacement and calcium/vitamin D supplementation.</p><p class="bulletIndent1"><span class="glyph">●</span>Review surgical pathology results.</p><p class="bulletIndent1"><span class="glyph">●</span>Discuss plans for further treatment or observation. </p><p class="bulletIndent1"><span class="glyph">●</span>Coordinate multidisciplinary care for patients with thyroid cancer [<a href="#rid102">102</a>].</p><p></p><p class="headingAnchor" id="H27"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Complications of thyroid surgery include wound seroma or hematoma, hypocalcemia due to hypoparathyroidism, hoarseness or change in voice, vocal cord paresis or paralysis due to nerve injury, Horner syndrome, chyle fistula, tracheal or esophageal injury, and dysphagia. </p><p>An Italian study of 14,934 patients who underwent thyroid surgery (21 percent lobectomy, 64 percent total thyroidectomy, 9 percent subtotal thyroidectomy, 6 percent reoperation) reported that hemorrhage occurred in 1.2 percent, hypoparathyroidism in 10 percent (8.3 percent transient, 1.7 percent permanent), superior laryngeal nerve injury in 3.7 percent, recurrent laryngeal nerve injury in 3.4 percent (2 percent transient, 1 percent unilateral permanent, 0.4 percent bilateral permanent), and dysphagia in 1.4 percent of patients [<a href="#rid38">38</a>]. </p><p>In an international study of 2325 patients who underwent surgery for differentiated thyroid cancer, 25.8 percent reported voice changes persisting for longer than three months, 12.7 percent had an abnormal voice handicap index-10 score (VHI-10; which quantifies 10 psychosocial consequences of voice disorder), and 4.7 percent had initial detectable vocal fold motion abnormalities on laryngoscopy [<a href="#rid103">103</a>]. However, this study likely identified transient voice disorders, as permanent dysfunction is defined as lasting for 6 to 12 months. </p><p>The reported rates for each complication vary by geography but are generally somewhat considerably lower in the United States (US) than in other countries. Additionally, complication rates, particularly those of nerve injury, hypoparathyroidism, and dysphagia, are also lower in patients operated on by high-volume surgeons and/or at high-volume centers [<a href="#rid104">104-110</a>]. One study found that the likelihood of experiencing a complication after total thyroidectomy decreased when the surgeon performed &gt;25 total thyroidectomies per year [<a href="#rid110">110</a>].</p><p>In a study of more than 8000 patients in the US Collaborative Endocrine Surgery Quality Improvement Program (CESQIP), the rates of all emergency room visits and all hospital readmissions were 3.4 and 2.3 percent, respectively [<a href="#rid111">111</a>]. Hypocalcemia was the reason for 22 percent of emergency room visits and 36 percent of the readmissions. Severe obesity, long surgery, and recurrent laryngeal nerve injury were risk factors for return visits. </p><p class="headingAnchor" id="H28"><span class="h2">Hematoma</span><span class="headingEndMark"> — </span>Postoperative hematoma is a rare but potentially fatal complication of thyroid surgery [<a href="#rid38">38,112-114</a>]. In a retrospective review of 150,012 patients, 1.25 percent developed a postoperative hematoma, and in other studies the rate ranged from 0.7 to 1.5 percent [<a href="#rid6">6,115</a>]. The mortality rate was much higher with a hematoma (1.34 versus 0.32 percent) [<a href="#rid114">114</a>]. </p><p>To prevent postoperative bleeding and hematoma formation, patients should stop all anticoagulants before surgery; hemostasis must be meticulously maintained during surgery. Additionally, the following conditions have been associated with postoperative hematoma formation by multivariate analyses [<a href="#rid114">114,116</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Inflammatory thyroid conditions (odds ratio [OR] 1.59, 95% CI 1.23-2.06)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Partial thyroidectomy (OR 1.69, 95% CI 1.20-2.37)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic renal disease (predisposition to bleeding disorders; OR 1.8, 95% CI 1.08-3.03)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bleeding disorders (OR 3.38, 95% CI 1.76-6.50) [<a href="#rid114">114</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Graves' disease (OR 2.43, 95% CI 1.22-4.85 [<a href="#rid116">116</a>]; OR 1.58, 95% 1.09-2.31 [<a href="#rid117">117</a>])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Benign pathology (OR 2.22, 95% CI 1.35-3.57)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antiplatelet/anticoagulation medications (OR 2.12, 95% CI 1.10-4.13)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of a hemostatic agent (OR 1.97, 95% CI 1.21-3.18)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of a drain (OR 2.79, 95% CI 1.68-4.65) [<a href="#rid116">116</a>]</p><p></p><p>A cervical hematoma is characteristically a large, tense, firm, immobile anterior or lateral cervical swelling under the incision. After surgery, the surgical team should routinely examine the patient for signs or symptoms of a hematoma including wound inspection, pain scoring, as well as being aware of more subtle signs such as discomfort, agitation, anxiety, or difficulty in breathing [<a href="#rid118">118</a>]. </p><p>Any hematoma that causes airway compromise should be opened at the bedside, for which a post-thyroid surgery emergency box containing essential surgical tools should always be available, including during transfer. We recommend using the SCOOP approach (skin exposure; cut sutures; open skin; open muscles [superficial and deep] layers; pack wound), before the patient is further evaluated and returned to the operating room for formal exploration of a potential source [<a href="#rid118">118</a>]. </p><p>A post-thyroidectomy hematoma in a patient without immediate concern for airway compromise should be evacuated in the operating room. In a retrospective study of 207 patients who developed a hematoma after thyroidectomy, 79 percent required operating room evacuation within 24 hours of the original surgery. Patients diagnosed with a hematoma should be kept awake and promptly transported to the operating room for evacuation. In the operating room, in most cases the patient's neck should be cleansed with antiseptics, the incision opened, and blood from the hematoma evacuated all <strong>prior to</strong> intubation, as a large cervical hematoma might make intubation more difficult by compressing the larynx.</p><p>Once the airway is secured by intubation, the hematoma should be completely evacuated and hemostasis established with meticulous techniques. The hematoma is usually in the paratracheal area. Thus, the strap muscle closure should be reopened to allow inspection and evacuation of this compartment. The recurrent laryngeal nerves (RLNs) and parathyroid glands should be carefully preserved to avoid a secondary injury; blind use of electrocautery near the ligament of Berry must be avoided. Placement of a drain facilitates prompt evacuation of serous fluid that may accumulate in the bed of the hematoma. Patients may require overnight intubation to allow supraglottic edema to subside before extubation. </p><p class="headingAnchor" id="H29"><span class="h2">Seroma</span><span class="headingEndMark"> — </span>Wound seromas are typically superficial, mobile, and likely to resolve without any intervention.</p><p class="headingAnchor" id="H30"><span class="h2">Hypocalcemia/hypoparathyroidism</span><span class="headingEndMark"> — </span>Hypocalcemia is one of the most common complications of thyroidectomy [<a href="#rid119">119</a>]. Symptoms of hypocalcemia range from mild (eg, paresthesias around the lips, mouth, hands, and feet) or moderate (eg, muscle twitches or frank cramps) to severe (eg, trismus or tetany). (See  <a class="medical medical_review" href="/z/d/html/833.html" rel="external">"Clinical manifestations of hypocalcemia"</a>.)</p><p>While all patients with symptomatic hypocalcemia require oral calcium and some may need to be managed with additional intravenous calcium or <a class="drug drug_general" data-topicid="9183" href="/z/d/drug information/9183.html" rel="external">calcitriol</a>, asymptomatic patients may or may not need calcium supplementation (at the surgeon's discretion). (See <a class="local">'Calcium supplementation'</a> above.)</p><p>Transient hypoparathyroidism has been reported in 0.3 to 49 percent of patients after thyroidectomy; up to 13 percent of post-thyroidectomy hypoparathyroidism becomes permanent [<a href="#rid119">119</a>]. However, the clinical definition of hypoparathyroidism is controversial, which limits the analysis of its rates after thyroidectomy. We counsel our patients that the risk of permanent hypoparathyroidism after a total thyroidectomy by an experienced surgeon in the United States is approximately 2 percent. </p><p>Intraoperative <a class="drug drug_general" data-topicid="8982" href="/z/d/drug information/8982.html" rel="external">indocyanine green</a> (ICG) angiography has been used in thyroid surgery to predict postoperative hypoparathyroidism. In a randomized trial, none of the 146 patients who had at least one well-perfused parathyroid gland on ICG angiography developed postoperative hypocalcemia with or without laboratory tests and calcium supplementation, which did not affect surgical results. By contrast, 11 of 50 patients who did not have any well-perfused parathyroid gland on ICG angiography developed hypocalcemia on postoperative day 1, and 6 on postoperative days 10 to 15 [<a href="#rid120">120</a>].</p><p>Parathyroid tissue, when submitted to near-infrared stimulation, emits a spontaneous autofluorescent signal termed near-infrared-induced autofluorescence (NIRAF). In a European trial (PARAFLUO) of 245 patients undergoing total thyroidectomy, the use of NIRAF intraoperative imaging of the parathyroids resulted in a decrease in the rate of temporary postoperative hypocalcemia (9 versus 22 percent), parathyroid autotransplantation (4 versus 16 percent), and inadvertent parathyroid resection (3 versus 14 percent) [<a href="#rid121">121</a>]. </p><p class="headingAnchor" id="H3933138535"><span class="h2">Hoarseness</span><span class="headingEndMark"> — </span>Hoarseness is common after thyroid surgery. Transient hoarseness that resolves spontaneously in 24 to 48 hours is typically due to vocal cord edema caused by endotracheal intubation. Persistent or severe hoarseness is rare and can be caused by arytenoid dislocation or vocal cord dysfunction from a nerve injury [<a href="#rid122">122-124</a>]. </p><p>Arytenoid dislocation is an unusual consequence of endotracheal intubation that can cause hoarseness, vocal fatigue, and dysphagia. Arytenoid dislocation should be promptly treated with reduction and repositioning of the arytenoid cartilage [<a href="#rid125">125</a>]. </p><p>Symptomatic voice changes generally improve after the immediate postoperative period. Hoarseness, uncontrolled coughing when talking, dyspnea that persists for more than 24 to 48 hours after surgery, or aspiration pneumonia should raise suspicion for possible vocal cord motion abnormalities. Such patients should be referred promptly for direct laryngoscopy and a complete neurolaryngeal evaluation [<a href="#rid126">126</a>]. </p><p class="headingAnchor" id="H122523"><span class="h2">Nerve injury/vocal cord paresis or paralysis</span><span class="headingEndMark"> — </span>Nerve injury can result from the underlying thyroid disease process, surgery, or anesthesia-related airway manipulation (eg, endotracheal intubation). Three nerves can potentially be injured during thyroid surgery: </p><p class="bulletIndent1"><span class="glyph">●</span>Superior laryngeal nerve (SLN) – Injury to the external branch of the SLN results in voice weakness or fatigue as well as changes to both quality and pitch of the voice [<a href="#rid127">127</a>]. (See <a class="local">'Superior laryngeal nerve injury'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent laryngeal nerve – Injury to the RLN results in the ipsilateral true vocal cord being paretic or paralyzed in a paramedian or lateral position. Intrinsic muscles of the larynx, except the cricothyroid muscle, are denervated, and the patient may have swallowing difficulties and an increased aspiration risk. (See <a class="local">'Recurrent laryngeal nerve injury'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vagus nerve – High transection or injury to the vagus nerve near the carotid bulb paralyzes both the SLN and the RLN. This can result in both sensory and motor deficits of the larynx, which are significant risk factors for aspiration. </p><p></p><p class="headingAnchor" id="H122759"><span class="h3">Superior laryngeal nerve injury</span><span class="headingEndMark"> — </span>Isolated SLN injury only produces vocal fatigue and subtle changes in voice quality in timbre, pitch, and voice projection. Due in part to difficulties in accurate diagnosis, rates of SLN injury after thyroidectomy are difficult to determine. In one study, SLN injury was seen after approximately 4 percent of thyroid surgeries [<a href="#rid38">38</a>]. Patients should be counseled preoperatively that they may experience permanent pitch change or have permanent difficulty singing high notes or speaking at a loud volume after surgery. </p><p>SLN injury is typically diagnosed with a complete neurolaryngeal evaluation, which could include specialized procedures such as rigid or flexible videostroboscopy or laryngeal electromyography [<a href="#rid126">126</a>]. Aerodynamic assessment of voice production and objective acoustic voice evaluation are also helpful in following improvement over time. </p><p class="headingAnchor" id="H31"><span class="h3">Recurrent laryngeal nerve injury</span><span class="headingEndMark"> — </span>Iatrogenic injury to the RLN is one of the most concerning complications of thyroid surgery [<a href="#rid128">128</a>]. In various studies, rates of RLN injury ranged from 0 to 7.1 percent for transient injury and 0 to 11 percent for permanent injury; lower rates of RLN injury were achieved by higher-volume surgeons [<a href="#rid104">104-106,129</a>].</p><p class="headingAnchor" id="H32"><span class="h4">Vocal cord paresis</span><span class="headingEndMark"> — </span>Typically caused by a traction injury to the RLN, vocal cord paresis is usually transient and does not require intervention. However, referral to a voice or speech therapist can help protect the patient's voice, reduce strain, reduce anxiety, and improve vocalization. The vocal cord should typically be reexamined at three and six months. Temporary vocal cord paresis usually resolves by six months. If the vocal cord is immobile for longer than six months, permanent paralysis is likely. (See <a class="local">'Unilateral vocal cord paralysis'</a> below.)</p><p class="headingAnchor" id="H33"><span class="h4">Unilateral vocal cord paralysis</span><span class="headingEndMark"> — </span>RLN injury can result in the ipsilateral true vocal cord being paralyzed in a paramedian or lateral position. Medialization of the paralyzed vocal cord improves both swallowing and phonating by allowing the contralateral functioning vocal cord to close off the larynx. A vocal cord paralyzed in the lateral position can be temporarily medialized by injection of fat, silicone, or collagen [<a href="#rid130">130,131</a>]. In patients with permanent deficits (persisting for more than 6 to 12 months after the initial thyroid surgery), collagen can be injected for medialization of the paralyzed vocal cord [<a href="#rid131">131,132</a>]. </p><p>Early surgical medialization of a paralyzed vocal cord is indicated in patients with severe symptoms such as aspiration pneumonia, disabling breathy hypophonia, ineffective cough, or disabling dyspnea. Patients who have mild symptoms should undergo voice/speech therapy. Those who do not respond to voice/speech therapy after six to nine months and who demonstrate evidence of denervation or little activity on laryngeal electromyography should undergo surgical medialization of the paralyzed vocal cord [<a href="#rid133">133</a>]. </p><p class="headingAnchor" id="H34"><span class="h4">Bilateral vocal cord paralysis</span><span class="headingEndMark"> — </span>Bilateral vocal cord paralysis from injuries to both RLNs is a rare (0.4 percent of cases) but devastating complication of total thyroidectomy that occurs most commonly with reoperations [<a href="#rid38">38</a>]. Bilateral vocal cord paralysis is usually recognized immediately after surgery when the patient develops dyspnea and stridor upon extubation. Immediate reintubation is usually possible, but a tracheostomy may be required if the patient cannot be orotracheally reintubated (eg, if both vocal cords are adducted). </p><p>In patients who have permanent bilateral vocal cord paralysis, a partial posterior cordectomy using laser surgery can restore sufficient laryngeal airflow with minimal vocal sequelae and avoid long-term tracheostomy. Bilateral vocal cord paralysis should be managed by a multidisciplinary team for optimal outcomes [<a href="#rid126">126</a>].</p><p class="headingAnchor" id="H2785065103"><span class="h3">Techniques of nerve repair</span><span class="headingEndMark"> — </span>If an RLN injury is identified intraoperatively, nerve repair should be attempted, when feasible, to promote synkinesis [<a href="#rid6">6,134</a>]. </p><p>Injured nerves with clean, fresh edges; good hemostasis; and without tension on either end have the best chance of a successful repair. Avulsion or cautery injuries are more difficult to repair than a sharp transection. </p><p>The surgical options include direct end-to-end anastomosis (neurorrhaphy), direct implantation of a nerve ending into the thyroarytenoid muscle, or muscle-nerve pedicle grafting using ansa cervicalis. A fine nonabsorbable suture is typically used for the repair. </p><p>If the transected nerve appears foreshortened, an interposition nerve graft with a diameter comparable to that of the RLN can be used [<a href="#rid135">135,136</a>]. Commonly used interposition grafts in the neck include the ansa cervicalis nerve and the hypoglossal nerve.</p><p>The techniques of nerve repair are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/14170.html" rel="external">"Traumatic peripheral neuropathies", section on 'Treatment overview'</a>.)</p><p class="headingAnchor" id="H2081321168"><span class="h2">Dysphagia</span><span class="headingEndMark"> — </span>Dysphagia is a frequent complaint both before and after thyroid surgery. The etiology of post-thyroidectomy dysphagia is uncertain but may be related to postoperative adhesions, decreased laryngeal elevation, cricothyroid trauma or inflammation, or perithyroidal nerve damage. </p><p>Despite an initial decline in the immediate postoperative period, patients without an RLN injury generally experience improvement in their swallowing function at six months after surgery compared with at the preoperative baseline [<a href="#rid137">137</a>], which may be attributed to resolution of compressive symptoms.</p><p>In one study, 47 percent of patients who underwent total thyroidectomy had swallowing complaints before surgery, 74 percent during the first week after surgery, and only 20 percent at six months [<a href="#rid137">137</a>]. In another study, 57 percent of patients reported swallowing problems before thyroid surgery, but only 8 percent had persistent symptoms at six months after surgery [<a href="#rid138">138</a>]. Anecdotally, incisional massage may greatly improve postoperative dysphagia. </p><p class="headingAnchor" id="H36"><span class="h2">Horner syndrome</span><span class="headingEndMark"> — </span>Horner syndrome is a neurologic syndrome caused by disruption of the sympathetic pathway that supplies the head, eye, and neck. The symptoms of Horner syndrome are miosis, ptosis, and anhidrosis. Horner syndrome is a very rare (0.2 percent) complication of thyroidectomy that is most often associated with a lateral neck dissection [<a href="#rid139">139</a>]. The sympathetic chain can be disrupted due to ischemic nerve damage, stretching of the cervical sympathetic chain by the retractor, or postoperative hematoma. Injury to the sympathetic chains can be minimized with careful dissection around the prevertebral fascia and carotid sheath. (See  <a class="medical medical_review" href="/z/d/html/5249.html" rel="external">"Horner syndrome"</a>.)</p><p class="headingAnchor" id="H37"><span class="h2">Chyle leak</span><span class="headingEndMark"> — </span>Chyle leaks or fistulas are caused by injury to the thoracic duct. Chyle leak is reported in 1.8 to 8.3 percent of thyroidectomies. Although chyle leak occurs most often when a lateral lymph node dissection has been performed [<a href="#rid140">140</a>], it can occur with central neck dissection as well [<a href="#rid141">141</a>]. (See  <a class="medical medical_review" href="/z/d/html/6696.html" rel="external">"Etiology, clinical presentation, and diagnosis of chylothorax"</a>.)</p><p>Chyle leaks can lead to severe fluid and electrolyte imbalances and even death if not treated properly. They are generally indicated by milky drainage, a bulging supraclavicular fossa, and induration or erythema of the skin. Low-output chyle leak (&lt;500 mL/day) can be managed conservatively with fasting [<a href="#rid141">141</a>]; high-output leaks require surgical ligation of the thoracic duct [<a href="#rid140">140</a>].</p><p class="headingAnchor" id="H38"><span class="h2">Tracheal injury</span><span class="headingEndMark"> — </span>Tracheal necrosis secondary to excessive use of cautery on or around the trachea is a rare complication of thyroidectomy [<a href="#rid142">142</a>]. The blood supply to the upper trachea is primarily from small branches of the inferior thyroid artery, which could be damaged during thyroid surgery. Tracheal necrosis can lead to air leak or subcutaneous emphysema and is potentially life-threatening. Any tracheal injury requires neck reexploration and construction of a tracheostomy. (See  <a class="medical medical_review" href="/z/d/html/4389.html" rel="external">"Tracheostomy: Rationale, indications, and contraindications"</a>.)</p><p class="headingAnchor" id="H39"><span class="h2">Esophageal injury</span><span class="headingEndMark"> — </span>While rare, esophageal and pharyngeal injury can occur with thyroid surgery. The finding of extensive crepitus in the neck postoperatively should prompt immediate evaluation for a pharyngeal or esophageal perforation. (See  <a class="medical medical_review" href="/z/d/html/15062.html" rel="external">"Overview of esophageal injury due to blunt or penetrating trauma in adults"</a>.)</p><p class="headingAnchor" id="H1314991784"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/129060.html" rel="external">"Society guideline links: Thyroid surgery"</a>.)</p><p class="headingAnchor" id="H184178495"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/135267.html" rel="external">"Patient education: Seroma (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H41"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative evaluation</strong> – Thyroidectomy is usually an elective operation, and any major medical issues should be addressed before proceeding to surgery. (See <a class="local">'Preoperative evaluation and preparation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with hyperthyroidism should be medically optimized with antithyroid medications and/or a beta blocker prior to thyroid surgery to avoid thyroid storm. (See  <a class="medical medical_review" href="/z/d/html/7880.html" rel="external">"Surgical management of hyperthyroidism", section on 'Preoperative preparation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Diagnostic thyroid ultrasound should be performed in all patients with a suspected malignancy, thyroid nodule, nodular goiter, or abnormality detected on other imaging modalities. Imaging modalities such as computed tomography (CT) or magnetic resonance imaging (MRI) should be reserved for the assessment of patients with extensive extrathyroidal disease. (See <a class="local">'Preoperative evaluation and preparation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Preoperative laryngoscopy or laryngeal ultrasound should be performed for patients with preoperative hoarseness or voice changes, extrathyroidal disease extension, or bulky lymphadenopathy and for all patients undergoing reoperative surgery. (See <a class="local">'Preoperative evaluation and preparation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraoperative recurrent laryngeal nerve protection</strong> – Routine visual identification of the recurrent laryngeal nerve (RLN) decreases the incidence of injury and is regarded as the standard of care in thyroid surgery. Intraoperative nerve monitoring is an adjunctive measure that can be used to identify the nerve with the goal of reducing the risk of nerve injury but should not be relied upon as a substitute for good surgical technique. (See <a class="local">'Dissection of the thyroid gland'</a> above and <a class="local">'Intraoperative nerve monitoring'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraoperative frozen section analysis</strong> – Frozen section analysis during thyroid surgery should only be employed when it will have an impact on surgical decision making. (See <a class="local">'Intraoperative frozen section analysis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative management</strong> – The requirement for immediate thyroid hormone supplementation after thyroid surgery depends upon the patient's diagnosis (benign versus malignant) and the extent of their resection (total thyroidectomy versus thyroid lobectomy). (See <a class="local">'Thyroid hormone supplementation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients undergoing total thyroidectomy are at risk for developing transient or permanent hypoparathyroidism postoperatively. Some surgeons prescribe calcium supplementation routinely after thyroidectomy to prevent symptoms of hypocalcemia, whereas others do so selectively based upon postoperative serum calcium levels. Patients should be counseled to promptly report hypocalcemic symptoms such as circumoral paresthesias. (See <a class="local">'Calcium supplementation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hoarseness, uncontrolled coughing when the patient is talking, dyspnea persisting for more than 24 to 48 hours after thyroid surgery, or aspiration pneumonia should raise suspicion of potential vocal cord paralysis as a result of an RLN injury. Such patients should be evaluated promptly, including direct laryngoscopy. (See <a class="local">'Hoarseness'</a> above and <a class="local">'Nerve injury/vocal cord paresis or paralysis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rogers-Stevane J, Kauffman GL Jr. A historical perspective on surgery of the thyroid and parathyroid glands. Otolaryngol Clin North Am 2008; 41:1059.</a></li><li><a class="nounderline abstract_t">Loyo M, Tufano RP, Gourin CG. National trends in thyroid surgery and the effect of volume on short-term outcomes. Laryngoscope 2013; 123:2056.</a></li><li><a class="nounderline abstract_t">Kandil E, Noureldine SI, Abbas A, Tufano RP. The impact of surgical volume on patient outcomes following thyroid surgery. Surgery 2013; 154:1346.</a></li><li><a class="nounderline abstract_t">Adkisson CD, Howell GM, McCoy KL, et al. Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancer. Surgery 2014; 156:1453.</a></li><li><a class="nounderline abstract_t">Adam MA, Thomas S, Youngwirth L, et al. Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes? Ann Surg 2016.</a></li><li><a class="nounderline abstract_t">Patel KN, Yip L, Lubitz CC, et al. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg 2020; 271:e21.</a></li><li><a class="nounderline abstract_t">Mirallié E, Rigaud J, Mathonnet M, et al. Management and prognosis of metastases to the thyroid gland. J Am Coll Surg 2005; 200:203.</a></li><li><a class="nounderline abstract_t">Nixon IJ, Whitcher M, Glick J, et al. Surgical management of metastases to the thyroid gland. Ann Surg Oncol 2011; 18:800.</a></li><li><a class="nounderline abstract_t">Nixon IJ, Coca-Pelaz A, Kaleva AI, et al. Metastasis to the Thyroid Gland: A Critical Review. Ann Surg Oncol 2017; 24:1533.</a></li><li><a class="nounderline abstract_t">Patel KN, Yip L, Lubitz CC, et al. Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg 2020; 271:399.</a></li><li><a class="nounderline abstract_t">American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167.</a></li><li><a class="nounderline abstract_t">Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26:1.</a></li><li><a class="nounderline abstract_t">Stang MT, Armstrong MJ, Ogilvie JB, et al. Positional dyspnea and tracheal compression as indications for goiter resection. Arch Surg 2012; 147:621.</a></li><li><a class="nounderline abstract_t">Ukkat J, Gimm O, Brauckhoff M, et al. Single center experience in primary surgery for medullary thyroid carcinoma. World J Surg 2004; 28:1271.</a></li><li><a class="nounderline abstract_t">Schulte KM, Machens A, Fugazzola L, et al. The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A. J Clin Endocrinol Metab 2010; 95:E92.</a></li><li><a class="nounderline abstract_t">American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009; 19:565.</a></li><li><a class="nounderline abstract_t">Wong KP, Lang BH, Ng SH, et al. A prospective, assessor-blind evaluation of surgeon-performed transcutaneous laryngeal ultrasonography in vocal cord examination before and after thyroidectomy. Surgery 2013; 154:1158.</a></li><li><a class="nounderline abstract_t">Steurer M, Passler C, Denk DM, et al. Advantages of recurrent laryngeal nerve identification in thyroidectomy and parathyroidectomy and the importance of preoperative and postoperative laryngoscopic examination in more than 1000 nerves at risk. Laryngoscope 2002; 112:124.</a></li><li><a class="nounderline abstract_t">Zanocco K, Kaltman DJ, Wu JX, et al. Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer. Ann Surg Oncol 2018; 25:949.</a></li><li><a class="nounderline abstract_t">Shaha AR. Revision thyroid surgery - technical considerations. Otolaryngol Clin North Am 2008; 41:1169.</a></li><li><a class="nounderline abstract_t">Randolph GW, Kamani D. The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 2006; 139:357.</a></li><li><a class="nounderline abstract_t">Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 2016; 26:1343.</a></li><li><a class="nounderline abstract_t">Erbil Y, Ozluk Y, Giriş M, et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease. J Clin Endocrinol Metab 2007; 92:2182.</a></li><li><a class="nounderline abstract_t">Oltmann SC, Brekke AV, Schneider DF, et al. Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study. Ann Surg Oncol 2015; 22:952.</a></li><li><a class="nounderline abstract_t">Goldenberg D, Ferris RL, Shindo ML, et al. Thyroidectomy in patients who have undergone gastric bypass surgery. Head Neck 2018; 40:1237.</a></li><li><a class="nounderline abstract_t">Lefevre JH, Tresallet C, Leenhardt L, et al. Reoperative surgery for thyroid disease. Langenbecks Arch Surg 2007; 392:685.</a></li><li><a class="nounderline abstract_t">Levin KE, Clark AH, Duh QY, et al. Reoperative thyroid surgery. Surgery 1992; 111:604.</a></li><li><a class="nounderline abstract_t">Tan MP, Agarwal G, Reeve TS, et al. Impact of timing on completion thyroidectomy for thyroid cancer. Br J Surg 2002; 89:802.</a></li><li><a class="nounderline abstract_t">Uruno T, Masaki C, Suzuki A, et al. Antimicrobial prophylaxis for the prevention of surgical site infection after thyroid and parathyroid surgery: a prospective randomized trial. World J Surg 2015; 39:1282.</a></li><li><a class="nounderline abstract_t">Avenia N, Sanguinetti A, Cirocchi R, et al. Antibiotic prophylaxis in thyroid surgery: a preliminary multicentric Italian experience. Ann Surg Innov Res 2009; 3:10.</a></li><li><a class="nounderline abstract_t">Leaper DJ, Melling AG. Antibiotic prophylaxis in clean surgery: clean non-implant wounds. J Chemother 2001; 13 Spec No 1:96.</a></li><li><a class="nounderline abstract_t">Gagliardi AR, Fenech D, Eskicioglu C, et al. Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature. Can J Surg 2009; 52:481.</a></li><li><a class="nounderline abstract_t">Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.</a></li><li><a class="nounderline abstract_t">Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.</a></li><li><a class="nounderline abstract_t">Braxton CC, Gerstenberger PA, Cox GG. Improving antibiotic stewardship: order set implementation to improve prophylactic antimicrobial prescribing in the outpatient surgical setting. J Ambul Care Manage 2010; 33:131.</a></li><li><a class="nounderline abstract_t">Worni M, Schudel HH, Seifert E, et al. Randomized controlled trial on single dose steroid before thyroidectomy for benign disease to improve postoperative nausea, pain, and vocal function. Ann Surg 2008; 248:1060.</a></li><li><a class="nounderline abstract_t">Lang BH, Ng SH, Wong KP. Pain and surgical outcomes with and without neck extension in standard open thyroidectomy: a prospective randomized trial. Head Neck 2015; 37:407.</a></li><li><a class="nounderline abstract_t">Rosato L, Avenia N, Bernante P, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 2004; 28:271.</a></li><li><a class="nounderline abstract_t">Brunaud L, Zarnegar R, Wada N, et al. Incision length for standard thyroidectomy and parathyroidectomy: when is it minimally invasive? Arch Surg 2003; 138:1140.</a></li><li><a class="nounderline abstract_t">Waseem T, Ahmed SZ, Baig H, et al. Truncal vs Branch Ligation of Inferior Thyroid Arteries in Total Thyroidectomy: Does It Affect Postoperative Hypoparathyroidism? Otolaryngol Head Neck Surg 2021; 164:759.</a></li><li><a class="nounderline abstract_t">Barczyński M, Konturek A, Hubalewska-Dydejczyk A, et al. Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter. World J Surg 2010; 34:1203.</a></li><li><a class="nounderline abstract_t">Wilhelm SM, McHenry CR. Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves' disease in the United States. World J Surg 2010; 34:1261.</a></li><li><a class="nounderline abstract_t">Bilimoria KY, Zanocco K, Sturgeon C. Impact of surgical treatment on outcomes for papillary thyroid cancer. Adv Surg 2008; 42:1.</a></li><li><a class="nounderline abstract_t">Tuttle RM, Fagin JA, Minkowitz G, et al. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance. JAMA Otolaryngol Head Neck Surg 2017; 143:1015.</a></li><li><a class="nounderline abstract_t">Tuttle RM, Zhang L, Shaha A. A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management. Expert Rev Endocrinol Metab 2018; 13:77.</a></li><li><a class="nounderline abstract_t">Grant CS, Stulak JM, Thompson GB, et al. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006. World J Surg 2010; 34:1239.</a></li><li><a class="nounderline abstract_t">Alsubaie KM, Alsubaie HM, Alzahrani FR, et al. Prophylactic Central Neck Dissection for Clinically Node-Negative Papillary Thyroid Carcinoma. Laryngoscope 2022; 132:1320.</a></li><li><a class="nounderline abstract_t">Olson JA Jr, DeBenedetti MK, Baumann DS, Wells SA Jr. Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg 1996; 223:472.</a></li><li><a class="nounderline abstract_t">Wang B, Zhu CR, Liu H, et al. The Ability of Near-Infrared Autofluorescence to Protect Parathyroid Gland Function During Thyroid Surgery: A Meta-Analysis. Front Endocrinol (Lausanne) 2021; 12:714691.</a></li><li><a class="nounderline abstract_t">Kim DH, Lee S, Jung J, et al. Near-infrared autofluorescence-based parathyroid glands identification in the thyroidectomy or parathyroidectomy: a systematic review and meta-analysis. Langenbecks Arch Surg 2022; 407:491.</a></li><li><a class="nounderline abstract_t">Solórzano CC, Thomas G, Berber E, et al. Current state of intraoperative use of near infrared fluorescence for parathyroid identification and preservation. Surgery 2021; 169:868.</a></li><li><a class="nounderline abstract_t">Carnaille BM, Pattou FN, Oudar C, et al. Parathyroid incidentalomas in normocalcemic patients during thyroid surgery. World J Surg 1996; 20:830.</a></li><li><a class="nounderline abstract_t">Carter WB, Uy K, Ward MD, Hoying JB. Parathyroid-induced angiogenesis is VEGF-dependent. Surgery 2000; 128:458.</a></li><li><a class="nounderline abstract_t">Randolph GW, Dralle H, International Intraoperative Monitoring Study Group, et al. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope 2011; 121 Suppl 1:S1.</a></li><li><a class="nounderline abstract_t">Terris DJ, Chaung K, Duke WS. Continuous Vagal Nerve Monitoring is Dangerous and Should not Routinely be Done During Thyroid Surgery. World J Surg 2015; 39:2471.</a></li><li><a class="nounderline abstract_t">Suh I, Yingling C, Randolph GW, Duh QY. A Novel Method of Neuromonitoring in Thyroidectomy and Parathyroidectomy Using Transcutaneous Intraoperative Vagal Stimulation. JAMA Surg 2016; 151:290.</a></li><li><a class="nounderline abstract_t">Angelos P. Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues. Surg Clin North Am 2009; 89:1157.</a></li><li><a class="nounderline abstract_t">Grubbs EG, Rich TA, Li G, et al. Recent advances in thyroid cancer. Curr Probl Surg 2008; 45:156.</a></li><li><a class="nounderline abstract_t">Dralle H, Sekulla C, Haerting J, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004; 136:1310.</a></li><li><a class="nounderline abstract_t">Chan WF, Lang BH, Lo CY. The role of intraoperative neuromonitoring of recurrent laryngeal nerve during thyroidectomy: a comparative study on 1000 nerves at risk. Surgery 2006; 140:866.</a></li><li><a class="nounderline abstract_t">Cirocchi R, Arezzo A, D'Andrea V, et al. Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery. Cochrane Database Syst Rev 2019; 1:CD012483.</a></li><li><a class="nounderline abstract_t">Davey MG, Cleere EF, Lowery AJ, Kerin MJ. Intraoperative recurrent laryngeal nerve monitoring versus visualisation alone - A systematic review and meta-analysis of randomized controlled trials. Am J Surg 2022; 224:836.</a></li><li><a class="nounderline abstract_t">Pisanu A, Porceddu G, Podda M, et al. Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy. J Surg Res 2014; 188:152.</a></li><li><a class="nounderline abstract_t">Vasileiadis I, Karatzas T, Charitoudis G, et al. Association of Intraoperative Neuromonitoring With Reduced Recurrent Laryngeal Nerve Injury in Patients Undergoing Total Thyroidectomy. JAMA Otolaryngol Head Neck Surg 2016; 142:994.</a></li><li><a class="nounderline abstract_t">Barczyński M, Konturek A, Cichoń S. Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg 2009; 96:240.</a></li><li><a class="nounderline abstract_t">Sarı S, Erbil Y, Sümer A, et al. Evaluation of recurrent laryngeal nerve monitoring in thyroid surgery. Int J Surg 2010; 8:474.</a></li><li><a class="nounderline abstract_t">Dionigi G, Boni L, Rovera F, et al. Neuromonitoring and video-assisted thyroidectomy: a prospective, randomized case-control evaluation. Surg Endosc 2009; 23:996.</a></li><li><a class="nounderline abstract_t">Al-Qurayshi Z, Randolph GW, Alshehri M, Kandil E. Analysis of Variations in the Use of Intraoperative Nerve Monitoring in Thyroid Surgery. JAMA Otolaryngol Head Neck Surg 2016; 142:584.</a></li><li><a class="nounderline abstract_t">Bergenfelz A, Salem AF, Jacobsson H, et al. Risk of recurrent laryngeal nerve palsy in patients undergoing thyroidectomy with and without intraoperative nerve monitoring. Br J Surg 2016; 103:1828.</a></li><li><a class="nounderline abstract_t">Brajcich BC, McHenry CR. The utility of intraoperative nerve monitoring during thyroid surgery. J Surg Res 2016; 204:29.</a></li><li><a class="nounderline abstract_t">Thomusch O, Sekulla C, Walls G, et al. Intraoperative neuromonitoring of surgery for benign goiter. Am J Surg 2002; 183:673.</a></li><li><a class="nounderline abstract_t">Osamura RY, Hunt JL. Current practices in performing frozen sections for thyroid and parathyroid pathology. Virchows Arch 2008; 453:433.</a></li><li><a class="nounderline abstract_t">Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 2016; 151:959.</a></li><li><a class="nounderline abstract_t">Khanna J, Mohil RS, Chintamani, et al. Is the routine drainage after surgery for thyroid necessary? A prospective randomized clinical study [ISRCTN63623153]. BMC Surg 2005; 5:11.</a></li><li><a class="nounderline abstract_t">Sanabria A, Carvalho AL, Silver CE, et al. Routine drainage after thyroid surgery--a meta-analysis. J Surg Oncol 2007; 96:273.</a></li><li><a class="nounderline abstract_t">Pons Y, Gauthier J, Ukkola-Pons E, et al. Comparison of LigaSure vessel sealing system, harmonic scalpel, and conventional hemostasis in total thyroidectomy. Otolaryngol Head Neck Surg 2009; 141:496.</a></li><li><a class="nounderline abstract_t">Upadhyaya A, Hu T, Meng Z, et al. Harmonic versus LigaSure hemostasis technique in thyroid surgery: A meta-analysis. Biomed Rep 2016; 5:221.</a></li><li><a class="nounderline abstract_t">Siu JM, McCarty JC, Gadkaree S, et al. Association of Vessel-Sealant Devices vs Conventional Hemostasis With Postoperative Neck Hematoma After Thyroid Operations. JAMA Surg 2019; 154:e193146.</a></li><li><a class="nounderline abstract_t">Miccoli P, Berti P, Ambrosini CE. Perspectives and lessons learned after a decade of minimally invasive video-assisted thyroidectomy. ORL J Otorhinolaryngol Relat Spec 2008; 70:282.</a></li><li><a class="nounderline abstract_t">Miccoli P, Pinchera A, Materazzi G, et al. Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy. J Clin Endocrinol Metab 2009; 94:1618.</a></li><li><a class="nounderline abstract_t">Kang SW, Lee SC, Lee SH, et al. Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system: the operative outcomes of 338 consecutive patients. Surgery 2009; 146:1048.</a></li><li><a class="nounderline abstract_t">Adam MA, Speicher P, Pura J, et al. Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes. Ann Surg Oncol 2014; 21:3859.</a></li><li><a class="nounderline abstract_t">Chai YJ, Kim HY, Kim HK, et al. Comparative analysis of 2 robotic thyroidectomy procedures: Transoral versus bilateral axillo-breast approach. Head Neck 2018; 40:886.</a></li><li><a class="nounderline abstract_t">Pan JH, Zhou H, Zhao XX, et al. Robotic thyroidectomy versus conventional open thyroidectomy for thyroid cancer: a systematic review and meta-analysis. Surg Endosc 2017; 31:3985.</a></li><li><a class="nounderline abstract_t">Lee DJ, Chin CJ, Hong CJ, et al. Outpatient versus inpatient thyroidectomy: A systematic review and meta-analysis. Head Neck 2018; 40:192.</a></li><li><a class="nounderline abstract_t">Tuggle CT, Roman S, Udelsman R, Sosa JA. Same-day thyroidectomy: a review of practice patterns and outcomes for 1,168 procedures in New York State. Ann Surg Oncol 2011; 18:1035.</a></li><li><a class="nounderline abstract_t">Papoian V, Handy KG, Villano AM, et al. Randomized control trial of opioid- versus nonopioid-based analgesia after thyroidectomy. Surgery 2020; 167:957.</a></li><li><a class="nounderline abstract_t">Lancaster E, Inglis-Arkell C, Hirose K, et al. Variability in Opioid-Prescribing Patterns in Endocrine Surgery and Discordance With Patient Use. JAMA Surg 2019; 154:1069.</a></li><li><a class="nounderline abstract_t">Phitayakorn R, McHenry CR. Follow-up after surgery for benign nodular thyroid disease: evidence-based approach. World J Surg 2008; 32:1374.</a></li><li><a class="nounderline abstract_t">Haugen BR, Cooper DS, Emerson CH, et al. Expanding indications for recombinant human TSH in thyroid cancer. Thyroid 2008; 18:687.</a></li><li><a class="nounderline abstract_t">Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, Morreale de Escobar G. REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab 2005; 90:4946.</a></li><li><a class="nounderline abstract_t">Liu RH, Razavi CR, Chang HY, et al. Association of Hypocalcemia and Magnesium Disorders With Thyroidectomy in Commercially Insured Patients. JAMA Otolaryngol Head Neck Surg 2020; 146:237.</a></li><li><a class="nounderline abstract_t">Bellantone R, Lombardi CP, Raffaelli M, et al. Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy? Surgery 2002; 132:1109.</a></li><li><a class="nounderline abstract_t">Cayo AK, Yen TW, Misustin SM, et al. Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study. Surgery 2012; 152:1059.</a></li><li><a class="nounderline abstract_t">Bentrem DJ, Rademaker A, Angelos P. Evaluation of serum calcium levels in predicting hypoparathyroidism after total/near-total thyroidectomy or parathyroidectomy. Am Surg 2001; 67:249.</a></li><li><a class="nounderline abstract_t">Sywak MS, Palazzo FF, Yeh M, et al. Parathyroid hormone assay predicts hypocalcaemia after total thyroidectomy. ANZ J Surg 2007; 77:667.</a></li><li><a class="nounderline abstract_t">Noordzij JP, Lee SL, Bernet VJ, et al. Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. J Am Coll Surg 2007; 205:748.</a></li><li><a class="nounderline abstract_t">Castro A, Del Rio L, Gavilan J. Stratifying the Risk of Developing Clinical Hypocalcemia after Thyroidectomy with Parathyroid Hormone. Otolaryngol Head Neck Surg 2018; 158:76.</a></li><li><a class="nounderline abstract_t">Mathur A, Nagarajan N, Kahan S, et al. Association of Parathyroid Hormone Level With Postthyroidectomy Hypocalcemia: A Systematic Review. JAMA Surg 2018; 153:69.</a></li><li><a class="nounderline abstract_t">Wang TS, Cheung K, Roman SA, Sosa JA. To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy. Ann Surg Oncol 2011; 18:1293.</a></li><li><a class="nounderline abstract_t">Sanabria A, Rojas A, Arevalo J. Meta-analysis of routine calcium/vitamin D3 supplementation versus serum calcium level-based strategy to prevent postoperative hypocalcaemia after thyroidectomy. Br J Surg 2019; 106:1126.</a></li><li><a class="nounderline abstract_t">Carty SE, Doherty GM, Inabnet WB 3rd, et al. American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. Thyroid 2012; 22:395.</a></li><li><a class="nounderline abstract_t">Kovatch KJ, Reyes-Gastelum D, Hughes DT, et al. Assessment of Voice Outcomes Following Surgery for Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 2019; 145:823.</a></li><li><a class="nounderline abstract_t">Tuggle CT, Roman SA, Wang TS, et al. Pediatric endocrine surgery: who is operating on our children? Surgery 2008; 144:869.</a></li><li><a class="nounderline abstract_t">Sosa JA, Mehta PJ, Wang TS, et al. A population-based study of outcomes from thyroidectomy in aging Americans: at what cost? J Am Coll Surg 2008; 206:1097.</a></li><li><a class="nounderline abstract_t">Boudourakis LD, Wang TS, Roman SA, et al. Evolution of the surgeon-volume, patient-outcome relationship. Ann Surg 2009; 250:159.</a></li><li><a class="nounderline abstract_t">Sosa JA, Bowman HM, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998; 228:320.</a></li><li><a class="nounderline abstract_t">Stavrakis AI, Ituarte PH, Ko CY, Yeh MW. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery 2007; 142:887.</a></li><li><a class="nounderline abstract_t">Mitchell J, Milas M, Barbosa G, et al. Avoidable reoperations for thyroid and parathyroid surgery: effect of hospital volume. Surgery 2008; 144:899.</a></li><li><a class="nounderline abstract_t">Adam MA, Thomas S, Youngwirth L, et al. Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes? Ann Surg 2017; 265:402.</a></li><li><a class="nounderline abstract_t">Taye A, Inabnet WB 3rd, Pan S, et al. Post-thyroidectomy emergency room visits and readmissions: Assessment from the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP). Am J Surg 2020; 220:813.</a></li><li><a class="nounderline abstract_t">Bononi M, Amore Bonapasta S, Vari A, et al. Incidence and circumstances of cervical hematoma complicating thyroidectomy and its relationship to postoperative vomiting. Head Neck 2010; 32:1173.</a></li><li><a class="nounderline abstract_t">Harding J, Sebag F, Sierra M, et al. Thyroid surgery: postoperative hematoma--prevention and treatment. Langenbecks Arch Surg 2006; 391:169.</a></li><li><a class="nounderline abstract_t">Weiss A, Lee KC, Brumund KT, et al. Risk factors for hematoma after thyroidectomy: results from the nationwide inpatient sample. Surgery 2014; 156:399.</a></li><li><a class="nounderline abstract_t">Doran HE, Wiseman SM, Palazzo FF, et al. Post-thyroidectomy bleeding: analysis of risk factors from a national registry. Br J Surg 2021; 108:851.</a></li><li><a class="nounderline abstract_t">Campbell MJ, McCoy KL, Shen WT, et al. A multi-institutional international study of risk factors for hematoma after thyroidectomy. Surgery 2013; 154:1283.</a></li><li><a class="nounderline abstract_t">Quimby AE, Wells ST, Hearn M, et al. Is there a group of patients at greater risk for hematoma following thyroidectomy? A systematic review and meta-analysis. Laryngoscope 2017; 127:1483.</a></li><li><a class="nounderline abstract_t">Iliff HA, El-Boghdadly K, Ahmad I, et al. Management of haematoma after thyroid surgery: systematic review and multidisciplinary consensus guidelines from the Difficult Airway Society, the British Association of Endocrine and Thyroid Surgeons and the British Association of Otorhinolaryngology, Head and Neck Surgery. Anaesthesia 2022; 77:82.</a></li><li><a class="nounderline abstract_t">Lee YS, Nam KH, Chung WY, et al. Postoperative complications of thyroid cancer in a single center experience. J Korean Med Sci 2010; 25:541.</a></li><li><a class="nounderline abstract_t">Vidal Fortuny J, Sadowski SM, Belfontali V, et al. Randomized clinical trial of intraoperative parathyroid gland angiography with indocyanine green fluorescence predicting parathyroid function after thyroid surgery. Br J Surg 2018; 105:350.</a></li><li><a class="nounderline abstract_t">Benmiloud F, Godiris-Petit G, Gras R, et al. Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial. JAMA Surg 2020; 155:106.</a></li><li><a class="nounderline abstract_t">Audu P, Artz G, Scheid S, et al. Recurrent laryngeal nerve palsy after anterior cervical spine surgery: the impact of endotracheal tube cuff deflation, reinflation, and pressure adjustment. Anesthesiology 2006; 105:898.</a></li><li><a class="nounderline abstract_t">Chan TV, Grillone G. Vocal cord paralysis after laryngeal mask airway ventilation. Laryngoscope 2005; 115:1436.</a></li><li><a class="nounderline abstract_t">Cinar SO, Seven H, Cinar U, Turgut S. Isolated bilateral paralysis of the hypoglossal and recurrent laryngeal nerves (Bilateral Tapia's syndrome) after transoral intubation for general anesthesia. Acta Anaesthesiol Scand 2005; 49:98.</a></li><li><a class="nounderline abstract_t">Norris BK, Schweinfurth JM. Arytenoid dislocation: An analysis of the contemporary literature. Laryngoscope 2011; 121:142.</a></li><li><a class="nounderline abstract_t">Finck C. Laryngeal dysfunction after thyroid surgery: diagnosis, evaluation and treatment. Acta Chir Belg 2006; 106:378.</a></li><li><a class="nounderline abstract_t">Teitelbaum BJ, Wenig BL. Superior laryngeal nerve injury from thyroid surgery. Head Neck 1995; 17:36.</a></li><li><a class="nounderline abstract_t">Kern KA. Medicolegal analysis of errors in diagnosis and treatment of surgical endocrine disease. Surgery 1993; 114:1167.</a></li><li><a class="nounderline abstract_t">Dralle H, Sekulla C, Lorenz K, et al. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 2008; 32:1358.</a></li><li><a class="nounderline abstract_t">Laccourreye O, Papon JF, Kania R, et al. Intracordal injection of autologous fat in patients with unilateral laryngeal nerve paralysis: long-term results from the patient's perspective. Laryngoscope 2003; 113:541.</a></li><li><a class="nounderline abstract_t">Snyder SK, Angelos P, Carty SE, et al. Injection of bulking agents for laryngoplasty. Surgery 2018; 163:6.</a></li><li><a class="nounderline abstract_t">Remacle M, Lawson G. Results with collagen injection into the vocal folds for medialization. Curr Opin Otolaryngol Head Neck Surg 2007; 15:148.</a></li><li><a class="nounderline abstract_t">Hartl DM, Travagli JP, Leboulleux S, et al. Clinical review: Current concepts in the management of unilateral recurrent laryngeal nerve paralysis after thyroid surgery. J Clin Endocrinol Metab 2005; 90:3084.</a></li><li><a class="nounderline abstract_t">Yumoto E, Sanuki T, Kumai Y. Immediate recurrent laryngeal nerve reconstruction and vocal outcome. Laryngoscope 2006; 116:1657.</a></li><li><a class="nounderline abstract_t">Paniello RC. Laryngeal reinnervation. Otolaryngol Clin North Am 2004; 37:161.</a></li><li><a class="nounderline abstract_t">Crumley RL. Repair of the recurrent laryngeal nerve. Otolaryngol Clin North Am 1990; 23:553.</a></li><li><a class="nounderline abstract_t">Lombardi CP, Raffaelli M, De Crea C, et al. Long-term outcome of functional post-thyroidectomy voice and swallowing symptoms. Surgery 2009; 146:1174.</a></li><li><a class="nounderline abstract_t">Gohrbandt AE, Aschoff A, Gohrbandt B, et al. Changes of Laryngeal Mobility and Symptoms Following Thyroid Surgery: 6-Month Follow-Up. World J Surg 2016; 40:636.</a></li><li><a class="nounderline abstract_t">Cozzaglio L, Coladonato M, Doci R, et al. Horner's syndrome as a complication of thyroidectomy: report of a case. Surg Today 2008; 38:1114.</a></li><li><a class="nounderline abstract_t">Roh JL, Kim DH, Park CI. Prospective identification of chyle leakage in patients undergoing lateral neck dissection for metastatic thyroid cancer. Ann Surg Oncol 2008; 15:424.</a></li><li><a class="nounderline abstract_t">Park I, Her N, Choe JH, et al. Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer. Head Neck 2018; 40:7.</a></li><li><a class="nounderline abstract_t">Chauhan A, Ganguly M, Saidha N, Gulia P. Tracheal necrosis with surgical emphysema following thyroidectomy. J Postgrad Med 2009; 55:193.</a></li></ol></div><div id="topicVersionRevision">Topic 2157 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19040968" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A historical perspective on surgery of the thyroid and parathyroid glands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23737403" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : National trends in thyroid surgery and the effect of volume on short-term outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24238052" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The impact of surgical volume on patient outcomes following thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25456931" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26967630" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32079830" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15664095" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Management and prognosis of metastases to the thyroid gland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21046263" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Surgical management of metastases to the thyroid gland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27873099" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Metastasis to the Thyroid Gland: A Critical Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32079828" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19860577" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26462967" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22430090" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Positional dyspnea and tracheal compression as indications for goiter resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15517488" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Single center experience in primary surgery for medullary thyroid carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20554711" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19469690" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Medullary thyroid cancer: management guidelines of the American Thyroid Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23969288" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A prospective, assessor-blind evaluation of surgeon-performed transcutaneous laryngeal ultrasonography in vocal cord examination before and after thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11802050" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Advantages of recurrent laryngeal nerve identification in thyroidectomy and parathyroidectomy and the importance of preoperative and postoperative laryngoscopic examination in more than 1000 nerves at risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29417402" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19040977" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Revision thyroid surgery - technical considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16546500" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27521067" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17389702" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25212835" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29417651" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Thyroidectomy in patients who have undergone gastric bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17593385" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Reoperative surgery for thyroid disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1595056" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Reoperative thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12027996" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Impact of timing on completion thyroidectomy for thyroid cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25566977" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Antimicrobial prophylaxis for the prevention of surgical site infection after thyroid and parathyroid surgery: a prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19656389" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Antibiotic prophylaxis in thyroid surgery: a preliminary multicentric Italian experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11936388" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Antibiotic prophylaxis in clean surgery: clean non-implant wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20011184" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19216670" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15227616" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20228636" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Improving antibiotic stewardship: order set implementation to improve prophylactic antimicrobial prescribing in the outpatient surgical setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19092351" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Randomized controlled trial on single dose steroid before thyroidectomy for benign disease to improve postoperative nausea, pain, and vocal function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24431099" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Pain and surgical outcomes with and without neck extension in standard open thyroidectomy: a prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14961204" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14557134" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Incision length for standard thyroidectomy and parathyroidectomy: when is it minimally invasive?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32957817" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Truncal vs Branch Ligation of Inferior Thyroid Arteries in Total Thyroidectomy: Does It Affect Postoperative Hypoparathyroidism?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20174803" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20033406" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves' disease in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18953806" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Impact of surgical treatment on outcomes for papillary thyroid cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28859191" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30058863" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20012290" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34708877" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prophylactic Central Neck Dissection for Clinically Node-Negative Papillary Thyroid Carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8651738" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34759888" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The Ability of Near-Infrared Autofluorescence to Protect Parathyroid Gland Function During Thyroid Surgery: A Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34322746" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Near-infrared autofluorescence-based parathyroid glands identification in the thyroidectomy or parathyroidectomy: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33139065" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Current state of intraoperative use of near infrared fluorescence for parathyroid identification and preservation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8678958" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Parathyroid incidentalomas in normocalcemic patients during thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10965318" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Parathyroid-induced angiogenesis is VEGF-dependent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21181860" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26138874" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Continuous Vagal Nerve Monitoring is Dangerous and Should not Routinely be Done During Thyroid Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26535804" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A Novel Method of Neuromonitoring in Thyroidectomy and Parathyroidectomy Using Transcutaneous Intraoperative Vagal Stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19836490" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18346477" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Recent advances in thyroid cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15657592" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17188132" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The role of intraoperative neuromonitoring of recurrent laryngeal nerve during thyroidectomy: a comparative study on 1000 nerves at risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30659577" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35422329" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Intraoperative recurrent laryngeal nerve monitoring versus visualisation alone - A systematic review and meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24433869" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27490310" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Association of Intraoperative Neuromonitoring With Reduced Recurrent Laryngeal Nerve Injury in Patients Undergoing Total Thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19177420" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20601257" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Evaluation of recurrent laryngeal nerve monitoring in thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18806939" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Neuromonitoring and video-assisted thyroidectomy: a prospective, randomized case-control evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27101092" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Analysis of Variations in the Use of Intraoperative Nerve Monitoring in Thyroid Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27538052" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Risk of recurrent laryngeal nerve palsy in patients undergoing thyroidectomy with and without intraoperative nerve monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27451864" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The utility of intraoperative nerve monitoring during thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12095600" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Intraoperative neuromonitoring of surgery for benign goiter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18830623" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Current practices in performing frozen sections for thyroid and parathyroid pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27532368" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15946379" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Is the routine drainage after surgery for thyroid necessary? A prospective randomized clinical study [ISRCTN63623153].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17469110" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Routine drainage after thyroid surgery--a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19786219" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Comparison of LigaSure vessel sealing system, harmonic scalpel, and conventional hemostasis in total thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27446546" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Harmonic versus LigaSure hemostasis technique in thyroid surgery: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31532475" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Association of Vessel-Sealant Devices vs Conventional Hemostasis With Postoperative Neck Hematoma After Thyroid Operations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18971591" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Perspectives and lessons learned after a decade of minimally invasive video-assisted thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19223525" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19879615" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system: the operative outcomes of 338 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24934584" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29240281" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Comparative analysis of 2 robotic thyroidectomy procedures: Transoral versus bilateral axillo-breast approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28337546" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Robotic thyroidectomy versus conventional open thyroidectomy for thyroid cancer: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29120517" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Outpatient versus inpatient thyroidectomy: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21086054" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Same-day thyroidectomy: a review of practice patterns and outcomes for 1,168 procedures in New York State.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32127178" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Randomized control trial of opioid- versus nonopioid-based analgesia after thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31411647" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Variability in Opioid-Prescribing Patterns in Endocrine Surgery and Discordance With Patient Use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18311576" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Follow-up after surgery for benign nodular thyroid disease: evidence-based approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18630995" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Expanding indications for recombinant human TSH in thyroid cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15928247" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31917427" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Association of Hypocalcemia and Magnesium Disorders With Thyroidectomy in Commercially Insured Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12490862" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23068088" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11270883" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Evaluation of serum calcium levels in predicting hypoparathyroidism after total/near-total thyroidectomy or parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17635281" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Parathyroid hormone assay predicts hypocalcaemia after total thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18035257" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28895449" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Stratifying the Risk of Developing Clinical Hypocalcemia after Thyroidectomy with Parathyroid Hormone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29167863" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Association of Parathyroid Hormone Level With Postthyroidectomy Hypocalcemia: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21088914" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31236917" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Meta-analysis of routine calcium/vitamin D3 supplementation versus serum calcium level-based strategy to prevent postoperative hypocalcaemia after thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22352873" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31318375" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Assessment of Voice Outcomes Following Surgery for Thyroid Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19040991" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Pediatric endocrine surgery: who is operating on our children?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18501806" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : A population-based study of outcomes from thyroidectomy in aging Americans: at what cost?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19561457" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Evolution of the surgeon-volume, patient-outcome relationship.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9742915" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : The importance of surgeon experience for clinical and economic outcomes from thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18063073" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19040995" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Avoidable reoperations for thyroid and parathyroid surgery: effect of hospital volume.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28059969" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32115176" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Post-thyroidectomy emergency room visits and readmissions: Assessment from the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20029984" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Incidence and circumstances of cervical hematoma complicating thyroidectomy and its relationship to postoperative vomiting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16555087" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Thyroid surgery: postoperative hematoma--prevention and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24947642" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Risk factors for hematoma after thyroidectomy: results from the nationwide inpatient sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33608709" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Post-thyroidectomy bleeding: analysis of risk factors from a national registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24206619" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : A multi-institutional international study of risk factors for hematoma after thyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27481173" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Is there a group of patients at greater risk for hematoma following thyroidectomy? A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34545943" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Management of haematoma after thyroid surgery: systematic review and multidisciplinary consensus guidelines from the Difficult Airway Society, the British Association of Endocrine and Thyroid Surgeons and the British Association of Otorhinolaryngology, Head and Neck Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20357995" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Postoperative complications of thyroid cancer in a single center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29405252" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Randomized clinical trial of intraoperative parathyroid gland angiography with indocyanine green fluorescence predicting parathyroid function after thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31693081" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17065882" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Recurrent laryngeal nerve palsy after anterior cervical spine surgery: the impact of endotracheal tube cuff deflation, reinflation, and pressure adjustment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16094119" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Vocal cord paralysis after laryngeal mask airway ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15675991" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Isolated bilateral paralysis of the hypoglossal and recurrent laryngeal nerves (Bilateral Tapia's syndrome) after transoral intubation for general anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21181984" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Arytenoid dislocation: An analysis of the contemporary literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17017688" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Laryngeal dysfunction after thyroid surgery: diagnosis, evaluation and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7883547" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Superior laryngeal nerve injury from thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8256224" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Medicolegal analysis of errors in diagnosis and treatment of surgical endocrine disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18305996" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12616211" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Intracordal injection of autologous fat in patients with unilateral laryngeal nerve paralysis: long-term results from the patient's perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29129367" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Injection of bulking agents for laryngoplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17483681" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Results with collagen injection into the vocal folds for medialization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15728196" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Clinical review: Current concepts in the management of unilateral recurrent laryngeal nerve paralysis after thyroid surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16954999" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Immediate recurrent laryngeal nerve reconstruction and vocal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15062692" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Laryngeal reinnervation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2195436" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Repair of the recurrent laryngeal nerve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19958946" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Long-term outcome of functional post-thyroidectomy voice and swallowing symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26560148" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Changes of Laryngeal Mobility and Symptoms Following Thyroid Surgery: 6-Month Follow-Up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19039637" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Horner's syndrome as a complication of thyroidectomy: report of a case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17999116" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Prospective identification of chyle leakage in patients undergoing lateral neck dissection for metastatic thyroid cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29120521" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19884745" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Tracheal necrosis with surgical emphysema following thyroidectomy.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
